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A few studies have assessed the effects of the current levels of air quality in relation to stationary 
and indoor emission sources, monitoring sites and susceptible populations.  To address this issue, 
first, an ecological evaluation of admissions of the elderly aged ≥65 years and the PM10 for the 
period 1995-2000 was carried out to assess vulnerability of this population. Secondly, a 
longitudinal study was conducted during the period of May 2003 to May 2004 among adults 
aged 50 to 79 years who had a cardiopulmonary diagnosis and resided in Allegheny County. 
Each participant maintained a diary of symptoms, peak expiratory flow rates and daily activities 
for up to two months. 
           The ecological data showed high rates of admissions among the elderly. Individuals 
admitted multiple times often had a diagnosis related to acute conditions compared to the chronic 
diagnoses among those admitted only one-time. The admission category of whether an individual 
was admitted multiple times or one-time appeared to be significantly related to the PM10. The 
longitudinal study included a total of 32 participants, mean age 66. The average 24-hr PM10 level 
was 24.36 µg/m3. The results showed an association between PM10 and the cardiopulmonary 
symptoms suggesting a possible effect of air pollution. Additionally, the results of the continuous 
monitoring sites were highly correlated during both study periods. This finding proposes a 
review of the current federal and county air pollution monitoring strategies. Efforts should 
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be re-directed at appropriate apportionment of individuals’ exposure levels and examining 
 
possible sources of emissions that impact the living environments. This can be achieved 
 
through personal monitoring in conjunction with physiological assessments for improved 
 
exposure-outcome extrapolation.
 
The public health significance of this study is that the less severe incidences reported by 
participants do not often require urgent medical support, but can eventually burden the body’s 
physiological mechanism leading to hospitalization or death. The implication of the results is that 
the current ambient air quality standards do not appear to be entirely protective of all different  
population groups. The elderly who have underlying health conditions appear to be susceptible  
to the current exposure levels. 
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1.0 INTRODUCTION 
1.1 Statement of the Problem 
 
Exposure to low levels of ambient air pollution is a concern that has emerged in recent research 
reports. While strides have been made to ascertain air pollution cause-effect in different 
populations, very few studies have examined the effect of the current levels on elderly 
populations.  Even fewer studies have assessed the effect of polluting sources in relation to 
where people live.  
Prior to 1995, research studies reported on levels of exposure generally around 100 µg/m3 
and showed effects of mortality and morbidity in different populations (Brunekreef 1995). 
Earlier research that drew the public and health professionals’ attention to the effects of air 
pollution were due to exposure levels that were even higher than 100 µg/m3.  The major air 
pollution incidents included the Meuse River Valley, Belgium in 1930 in which high 
concentrations of air pollution resulted in an atmospheric inversion that accounted for 60 deaths 
of mostly the elderly with previous heart and lung problems (Kaj Rohom 1937; Bell and Davis 
2001). In addition, there is the Pennsylvania; Donora episode of 1948 where an atmospheric 
inversion occurred and resulted in 20 deaths and several hospitalizations (Bell and Davis 2001). 
And lastly, the London fog of 1952 claimed up to 4000 lives mainly the elderly and seriously ill 
patients (Greenbaum et al., 1999; Folinsbee 1993; Bell and Davis 2001).  It is estimated that 
particulate matter exposures during the time of the London fog were as high as 270 µg/m3, which 
is typically 5-19 times higher than the current standards (Bell and Davis 2001).   
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Other episodes occurred but with less degree of severity due in part to efforts of 
enactment of Clean Air Acts, and reduction and re-location of polluting industries.  Over the 
years, air quality has improved but recent studies suggest a link of both chronic and acute 
respiratory, and cardiovascular system responses in all age groups at lower levels of exposures 
(Brunekreef, Dockery & Krzyzanowski, 1995; Schwartz et al., 1993; Shepard et al., 1999; 
Lawrence Folisnbee 1993; Bernard et al., 2001, Greenbaum, Bachmann, Krewski, Samet et al., 
2001;  Bryson, 1998; Zemp et al., 1999; Vedal et al., 2003; Bateson and Schwartz 2004).  
The toxicological and physiological experiments in both animals and humans have 
dispelled doubts on air pollution cause and effect relationship. The studies have demonstrated 
that effect of air pollution on the respiratory and cardiovascular system effect is not a misnomer 
(Batalha, Saldiva, Clarke et al., 2002; Peters, et al., 2001; Watkinson et al., 2001; Schwartz, 
1999; Arden Pope III 2000; Donaldson et al., 2001). Details of the physiological mechanisms are 
in chapter 2.  
Numerous epidemiological research studies on air pollution have reported the effects of 
exposure to high concentrations of pollution that include cardiovascular diseases (Dockery et al., 
2001; Mann et al., 2002; Checkoway et al., 1999; Peters et al., 2000; Goldberg et al., 2003; 
Zannobetti et al., 2003), respiratory diseases (Braga et al., 2000; Crater et al., 2001; Brunekreef 
& Holgate 2002; Desqueyroux et al., 2002), hospital admissions (Schwartz 2000; Atkinson et al., 
1999; Morris, 2001), and diabetes (Zanobette & Schwartz 2002). Some studies have established 
the debilitating effects of air pollution in vulnerable age groups such as children (Keeler et al., 
2002; Delfino et al., 2002) and the elderly (Samet 2002; Desqueyroux et al., 2002; Penttinen et 
al., 2001; Liao et al., 1999; Schwartz 1993).   A few longitudinal studies reported on short-term 
effects of air pollution (Delfino et al., 2002 &2003; Penttinen et al., 2001; Osunsanya et al., 
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2001; Yu et al., 2000).  Penttinen et al., (2001) examined asthmatic adults for a correlation 
between deviations of peak expiratory flow rate (PEFR) volume and reported that the PM10, 
PM2.5-10 and PM 2.5 were positively associated with PEFR deviations.  
  Still, fewer studies have examined the acute effects of environmental exposures in 
relation to proximity to central air monitoring sites and neighborhood polluting stationary 
sources (Levy et al., 2002; Delfino et al., 2002 &2003; Osunsanya et al., 2001, Leaderer et al., 
1999). To assess the background exposure to individuals, proper assignment of ambient 
exposures should take into account the distance of the participants from air pollution monitoring 
sites and major pollution sites, in conjunction to other contributing exposures such as indoor 
sources. Semi-individual studies have been proposed (Kunzil and Tager 1997), where assessment 
of individual health outcome is carried out but the independent variable of ambient air exposure 
and meteorological covariates remain ecological.  Additionally, the effect of air pollution 
exposures can be improved by restricting the distance of exposure assignment within an 
arbitrarily assigned proximity to pollution sources and the monitoring sites.  
  
1.2 Objectives of the Study 
The goal of the Allegheny County short-term air pollution effects (SHAPE) study was to 
determine if there is an association between low levels of ambient air exposures and the 
incidence of cardiopulmonary symptoms and anti-inflammatory medication use in the study 
population. The area of health effects of PM10 and related compounds among the elderly adults 
in Allegheny County was approached in two ways: 
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1. An ecological framework, (i) to consider men and women aged 65years and older, in 
Allegheny County admitted to the hospitals during the years 1995–2000 for the purpose of 
describing the admitting and the discharge diagnosis, and rates of admission of individuals who 
were admitted only one time and those who were admitted more than one time, and (ii) an 
analysis of the relationship between air pollution and the hospital admission during the same 
time period. 
2. A study of the short-term effects of ambient exposures through assessment of pulmonary 
function, respiratory and cardiac disease symptoms and anti-inflammatory medication uses in   
adults aged 50-79 years who have pre-existing cardiopulmonary diagnosis and who live in 
Allegheny County. This study was proposed to determine if daily changes in air pollution 
measured at the Allegheny County Health Department (ACHD) monitoring sites correlate with 
acute responses of symptoms, use of anti-inflammatory medication and pulmonary function 
changes. The SHAPE study considered also a relationship between individual residence and 
major air emission facilities identified from the EPA Toxic Registry Inventory (TRI) by 
recruiting people who lived within 15 km of the identified facility. 
 
1.3 Significance of the Study 
The SHAPE study is a follow up study to a retrospective ecological evaluation of the relationship 
between air pollution emissions and hospital admission rates for the period January, l995- 
December, 2000 in Allegheny County among adults ≥65 years old. Data from the PA Hospital 
Cost Containment Council (PACCC) which contains all in-patient hospital admissions of 
Allegheny County residents was used in the analysis. The admissions included International 
Classification of Disease (ICD)-9 codes 390 through 459 (cardiovascular and circulatory) and 
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460 through 519 (respiratory system). The data showed a total of 252,612 hospital admissions for 
cardiopulmonary diseases among the elderly (≥65 years old) with a mean age of 77.5 years and a 
mean length of hospital stay of 6.73 days. The admissions included 56,391 individuals admitted 
multiple times, mean age 76.77, and 58,373 individuals of mean age 77.54 admitted only one-
time during the study period.   
Ambient air levels of the criteria pollutants for all Allegheny County monitoring sites for 
January 1995 through December 2000 were obtained from the ACHD. In general air pollutant 
levels have decreased during the study period, though Lincoln and Liberty Borough showed 
consistently higher PM10 concentration levels compared to other sites.  
 In an earlier study of Allegheny County residents, Mazumdar and Sussman (1983), 
showed a significant risk estimate of 2.15 for total mortality and 3.14 for heart disease for all 
ages, for the same day particulates as measured by coefficient of haze (COH) values ranging 
from 0-3.5 units from the Hazelwood monitoring site data. When the authors analyzed the data 
of the age group ≥60 years, they yielded similar risk estimates. In terms of morbidity effects, 
Mazumdar and Sussman (1983) reported consistently significant associations between COH and 
total morbidity for the data of all the air pollution-monitoring sites (Hazelwood, Bellleuve, 
Logans Ferry) and for all ages.  
The SHAPE follow-up study evaluated the effects of low-level ambient air pollution on 
adult individuals with pre-existing cardiopulmonary diseases because of the described patho-
physiological mechanisms, the gaps in previous epidemiological-ecological studies and a need to 
strengthen and advance the science of environmental epidemiology through the proposed 
approach. Because this longitudinal short-term exposure study was a semi-individual design, this 
reduces the ecological fallacy that occurs with group associations.  Allegheny County is also 
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ideal for this type of study because of the topography of very irregular deep river valleys and 
steep hills of 300-500 ft above valleys (Mazumdar and Sussman 1983) and makes for entrapment 
of ambient pollutants during a temperature inversion.  These topographic characteristics make it 
uncertain to extrapolate other regional air pollution study results to the local population.  
This study investigated the relationship between the average 24-hr PM10 increments and 
cardiopulmonary symptoms including pulmonary function as measured by a decrement in peak 
expiratory flow rate (PEFR). The results from this study will contribute to knowledge that can 
guide collaborative communication to inform the public of the impact of air pollution and 
influence a review of the strategies to air quality monitoring by the county, state and federal 
agencies.  A survey study by Greenberg (2004) reported a decline of the public support for the 
antipollution regulations especially among the less affluent. Hence sharing of information from 
research of local and regional studies may be beneficial in education and empowerment of the 
general public about air quality in their communities and the effects to such exposures.   
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2.0 LITERATURE REVIEW 
 
The link between air pollution and health has been a topic of much debate and investigation over 
the last several decades.  Many studies have in particular examined the effects particulate matter 
(PM) because of the complex composition of the PM10 particles (Pope et al., 1997; Dockery 
2001; Schwartz 1983; Delfino 2003). PM is the general term used for a mixture of solid particles 
and liquid droplets found in the air. The chemical composition of particles depends on location, 
time of year, and weather.  PM can result from primary emissions such as dust from roads or 
elemental carbon (soot) from wood combustion, and other industrial processes and primary 
gaseous emissions. These include sulfate, formed from sulfur dioxide (SO2), power plants and 
industrial facilities; and nitrates, formed from Nitrogen Oxides (NOx), automobiles and other 
types of combustion sources.  
PM10 is one of the seven criteria air pollutants that the US Environmental Protection 
Agency (USEPA) regulates under the National Ambient Air Quality Standards (NAAQS).  PM10 
is defined as PM with a mass median aerodynamic diameter less than 10 micrometer. The current 
USEPA standard for the PM10 is composed of both an acute (24-hr allowable average) and 
chronic component (annual allowable average). The standard is a 24-hr average not to exceed 
150 micrograms per cubic meter of air (µg/m³) more than three times in three years and an 
annual arithmetic average not to exceed a 50 µg/m³ (EPA National Ambient Air Quality 
Standards, 1997).   
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2.1 History of Air pollution 
Major episodes of air pollution in which excess morbidity and mortality were reported have 
influenced policy and research at a global level. These major episodes include the Meuse River 
Valley, Belgium in 1930 in which high concentrations of air pollution resulted in an atmospheric 
inversion which accounted for 60 deaths of mostly the elderly with previous heart and lung 
problems (Kaj Rohom 1937; Bell and Davis 2001); the Pennsylvania, Donora episode of 1948 
where an atmospheric inversion resulted in 20 deaths and several hospitalizations (Bell and 
Davis 2001; Helfand et al., 2001); and the London fog of 1952 which claimed by far the highest 
number of lives of up to 4000 deaths mainly the elderly and seriously ill patients (Greenbaum, 
Bachmann, Krewski, et al., 2001; Folinsbee (1993), Bell and Davis 2001).  It is estimated that 
particulate matter exposures during the time of the London fog was as high as 270 ug/m3 which 
is typically 5-19 times higher than the current standards (Bell and Davis 2001).  
These episodes provided indisputable evidence of the cause and effect of air pollution 
and led to the promulgation of the Clean Air Act of 1970 and the establishment of the National 
Ambient Air Quality Standard (NAAQ) for regulating criteria pollutants (nitrogen dioxide, sulfur 
dioxides, carbon monoxide, particulate matter (PM10, PM2.5), ozone, benzene.) Current research 
has been influenced by some of these major incidents. 
Recent epidemiological studies on environmental exposures to air pollution have assessed 
a variety of pollutants and disease outcomes (von Klot et al., 2002, Yu et al., 2000; Penttinen et 
al., 2001; Brunekreef & Hoek 1993; Brunekreef et al., 1995; Desqueyroux et al., 2002) and have 
shown the need to continue to address the topic. Researchers continue to report on both acute and 
chronic disease outcomes due to air pollution exposures (Keeler et al., 2002; Delfino 2002). 
Other studies have reported on the patho-physiology mechanisms of air pollution (Batallha, 
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Salvida, and Clarke et al., (2002). Still others investigated the industrial and non-industrial 
stationary source pollutants and their contribution to air quality and conversely adverse health 
outcomes (Levy et al., 2002). Of concern is the disinterest and lack of support of the public of 
the antipollution regulations particularly among the less educated and also observed in the 
minority ethnic groups (Greenberg 2004). This lack of support may be due to problems in the 
public access to information and lack of knowledge on environmental concerns and to different 
competing economic challenges that the public experience.  
2.2 Patho- Physiological Mechanisms of Air Pollution 
2.2.1 Animal Studies 
 
Animal studies have shown possible mechanisms of air particulate exposure consequences on the 
cardiovascular and pulmonary systems. Batalha, Saldiva, Clarke et al., (2002) showed results 
that indicated short-term effects of particulate matter on the cardiovascular system. The study 
showed that short-term vasoconstriction of small pulmonary arteries can occur in normal male 
rats exposed to concentrated ambient particles at levels ranging from 73 – 733 µg/m³.  
Watkinson, Mathew, Campen et al., (2001) showed that when rats are exposed to 
particulate matter consistent with acute exposure, they exhibit deficits in heart rate with a 
decrease of 50-100 beats per minute (bpm), changes in metabolism, minute ventilation, blood 
pressure, cardiac output, adverse changes in cardiac waveforms, and cardiac rhythm, frequently 
resulting in fatal outcome in apparently healthy rats. The authors reported further that in their 
study, the rats that were cardiopulmonary compromised demonstrated exaggerated bradycardia 
and hypothermic responses.   
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Goldeski et al., (2000) reported that in a controlled exposure experiment of ambient 
particles, dogs that had compromised coronary artery function started to show changes in ECG 
within hours of onset of exposure, an indication of accelerated development of ischemic heart 
disease.  Costa and Dreher (1997) also showed ECG changes and lung inflammation in rats 
treated experimentally with soluble ash metals, an indication of acute inflammatory responses to 
particulate matter.  
 
2.2.2 Human Studies 
Human experimental studies have also reported on mechanism of pollutant-induced damage to 
the cardiovascular and pulmonary systems. Yeates and Manderly (2001) summarized studies on 
mechanisms of air pollution on cardiovascular and systematic responses and how non-respiratory 
organ health outcomes can occur following air pollution deposition in the respiratory. 
Peters et al., (2001) reported that healthy adults exposed to episodes of high particulate 
air pollution through inhalation of air particles can show outcomes of pulmonary inflammation 
that in turn trigger systemic hyper-coagulability, with increases in the viscosity of blood and     
C-reactive protein (CPR).  Similarly, Pope III (2001) reported on studies that showed alveolar 
inflammation resulting in the release of potentially harmful cytokines and increased blood 
coagulants, with autonomic nervous system-activated changes in blood viscosity, heart rate and 
heart rate variability (HRV) increasing the likelihood of cardiac death.  Peters et al., (1997) 
reported that exposure to ambient pollution can result in increased plasma viscosity that can lead 
to cardiovascular illness.  Donaldson et al., (2001) suggested a mechanism by which ultrafine 
particles can be deposited in the lungs of the elderly individual and cause a significant CPR 
increase. According to Donaldson et al., (2001), ultrafine PM can trigger oxidative stress and 
 10
inflammation in the lungs that can lead to a variety of pathologic endpoints such as atheromatous 
plaque, endothelial erosion and coagulation factors.  
Nemmar et al., (2001) assessed the mechanisms of passage of inhaled particles into the 
blood circulation of humans by measuring the distribution of radioactivity of the particles in five 
healthy volunteers. Radioactivity was detected in the blood already at 1 minute and reached 
maximum at 1-20 minutes and remained at higher levels up to 60-minutes. The experiment 
showed how particles translocate from lungs to cardiac circulation, causing circulatory system 
damage. According to Verrier et al., (2002) ambient air particulate matter consists of a mixture 
of combustive by-products and re-suspended crystal material as well as biological materials such 
as pollen, endotoxins, bacteria and viruses. The authors reported that these inhaled particles 
could be detected within minutes of exposure in systemic circulation where they persist for 
hours, providing a route of entry to other organs.  
Dockery (2001) described investigations on mechanisms by which particulates deposited 
in the lungs might produce an immediate fatal cardiac event.  In a study of hypoxemia and 
cardiac physiology Dockery (2001) reported significant relevant clinical marker of an increase of 
heart rate of more than 5 beats per minute (bpm) and 10 bpm (increased 29% and 95% 
respectively) for an increase in 100 ug/m3 exposure to PM10 on the previous day. Other studies 
have monitored dogs and shown morphologic changes on EKG output due to air particulate 
exposures (Godleski et al., 2000). 
In a short-term longitudinal study, Liao et al., (1999) monitored daily changes in 
particulate matter and cardiac autonomic activity and showed that at levels >15 µg/m3 of PM2.5 
the risk of lower cardiac autonomic control was 3.08 (95% CI 1.43, 6.59) suggesting a possible 
link between air pollution and cardiovascular disease mortality. Gold et al., (2000) and Stone et 
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al., (1999) also reported on path-physiological mechanisms that are likely to cause ECG changes, 
HRV or mortality in subjects. Brook and Brook et al., (2002), reported that after exposure of 
healthy adults to short term 2-hour exposure of 150 ug/m3 concentrated ambient fine particles 
plus 120 ppb ozone, they observed acute arterial vasoconstriction in the individuals.  The authors 
reported that the air pollution experimental exposures in their study are consistent with air 
pollution observed in urban cities. Ghio et al., (2000) exposed young healthy adults to ambient 
air particles and after 18 hours the lung tissues showed higher concentrations of neutrophils, a 
pathological marker of inflammation. In another study Ghio et al., (2003), showed that exposure 
of healthy individuals to concentrated air particles can be associated with decreases of both white 
blood cell count and LDH and increased concentrations of fibrinogen in the blood. 
Devlin et al., (2003) assessed HRV in healthy elderly adults between the ages of 60 and 
80 who were exposed twice for 2 hours: once to clean air and once to concentrated ambient air 
pollution particles. Participant’s responses were measured immediately before, immediately 
following, and again 24 hours after exposure. Elderly subjects experienced significant decreases 
in HRV in both time and frequency domains immediately following exposure compared to data 
of young healthy volunteers. Some of these changes persisted for at least 24 hours showing that 
the elderly individuals show decreased HRV to variable exposures levels.  
2.3 Air Pollution and Mortality 
Though many research studies continue to show mortality due to air pollution, Pope III et al., 
(1999) reported that more research is needed on specific pollutants, mixtures of pollutants and 
biological mechanisms.  A previous study by Mazumdar and Sussman (1983) showed a 
relationship between same day particulate levels and mortality and morbidity outcomes of 
respiratory and cardiovascular disease in Allegheny County, PA.  The study used the Hospital 
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Utilization Project and Presbyterian University Hospital data to examine morbidity outcomes due 
to particulate measured by the Coefficient of Haze (COH) and SO2 pollutants exposures.  Joel 
Schwartz (2000) examined 10 cities including Pittsburgh and reported an overall effect of 1.4% 
increase in deaths (95% CI= 1.15-1.68) for an increase in exposure of 10 ug/m3 on a single day.  
Another regional study was by Schwartz and Dockery (1992) examined an 11-year period data 
1974-1984 in Steubenville, Ohio and reported an association between daily 4% increase in 
mortality on a succeeding day for an increase in particulate matter of 100 µg/m³.  
In other regions, Goldberg, Burnett, Valois et al., (2003) analyzed data using all residents 
of Montreal who died during the period 1984-1993 and reported an increase in daily mortality 
for persons 65 years and older with mean percent increase in the coefficient of haze (COH) 
across the interquartile range 4.32% (95% CI: 0.95-7.80).  Pope, Burnett, Thun et al., (2002) 
reported increased risk of all-cause, cardiopulmonary and lung cancer of about 4%, 6% and 8% 
for each 10 µg/m³ increase of fine particulate.  
International studies have reported comparable results. In a Seoul study, Lee and 
Schwartz (1999) reported that premature death can occur due to particulate matter exposures and 
reported a relative risk of death of 1.010 (95% CI, 0.988-1.032) per 100 µg/m³ total suspended 
particles (TSP) exposure.  In the Netherlands, Hoek, Brunekreef, Goldbohm et al., (2002) 
showed that cardiopulmonary mortality was associated with living near major roads. Schwartz, 
Ballester, Saez et al., (2001) also reported on excess daily mortality from low levels of particles 
with a 10 µg/m³ resulting in 0.88% increase in deaths (95% CI, 0.56%- 1.20%) in eight Spanish 
cities.   
In Dublin, Ireland, Clancy et al., (2002) carried out an intervention study of the ban of 
coal use showed that after 72 months, about 116 fewer respiratory deaths and 243 fewer 
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cardiovascular deaths were seen per year which accounted for 5.7% decrease in respiratory death 
(95% CI, 4-7, p<0.0001) and cardiovascular by 10.3% (95% CI, 8-13, p<. 0001).   Generally, 
most studies on mortality appear to show effects at higher ambient air pollution levels than do 
morbidity studies. 
Levy et al. 2002, found that the higher level, of particle concentration was found in areas 
closest to the power plant and that these exposures may have impacted mostly those with lower 
education attainment. The mortality relative risk for an annual mean increase of 10 µg/m³ PM2.5 
concentration was noted to be 1.085 ((95% CI, 1.031-1.142) for individuals with less than high 
school education and 1.003 (95% CI, 0.9671-1.040) for individuals with more than high school 
education. 
2.4 Air Pollution and Morbidity 
Several studies have examined a correlation between air pollution levels and hospital admissions 
for cardiac and pulmonary diseases (Checkoway, et al., 2000; Schwartz 1999; Morris 2001; 
Atkinson et al., 1999; Peters et al., 2000, and came up with variable results. Studies have shown 
that PM10 levels at which health outcomes can be observed vary from as low as 24-hr minimum 
levels of 6.8 µg/m³ to a 24-hr maximum of 998 µg/m³ maximum (Atkinson et al., (1999). 
Brunekreef, et al., (1995) reported on health outcomes due to exposures PM not exceeding a 24-
hr average of 115 µg/m³.  Zanobetti et al., (2000) reported on deleterious health outcomes at 
exposure levels of 33 µg/m³ PM10 levels.  The studies show contrary results due to factors such 
as the type of pollutant under investigation, region of study, limitations of sample sizes and 
exposure misclassifications bias.   
 
 14
 
2.4.1 Respiratory Disease Outcomes 
Several studies have included both children and adults to assess the effects of environmental 
exposures in individuals with pre-existing respiratory diseases such as asthma, COPD and other 
respiratory diseases to explain the etiology of some of the disease burden.    
2.4.1.1 Asthma studies 
According to the ALA (2000), an estimated 31 million Americans had asthma diagnosed by a 
health professional. Delfino et al., (2002) investigated an association of asthma symptoms, anti-
inflammatory medication use and particulate air pollution in southern California. The study 
investigated 22 asthmatic children aged 9-19 years of age and followed them from March to 
April 1996. Asthma symptoms were recorded daily resulting in repeated measurements. The 
study showed a strong associations between an average of 7-32 µg/m³ of PM10, NO2, O3, and 
fungi and asthmatic kids not taking anti-inflammatory medicines (OR=2.80, 95% CI, 0.92-8.49), 
compared to those on anti-inflammatory (OR= 1.93, 95% CI, 1.01-3.71).                           
In another study, Delfino et al., (2003) examined asthma symptoms in Hispanic children 
and daily ambient exposures to toxic and criteria air pollutants in 22 children aged 10-15years of 
age with asthma living in Los Angeles where there is high traffic density. The study participants 
completed diaries of PEFR for three months November 1999 to January 2000. The home and 
school addresses were within a 3 mile radius of the central air pollutant measuring site enhancing 
the relevance of ambient exposure to personal exposures. The results showed that traffic air 
pollutants toxic mixture and industrial sources may be associated with adverse health outcomes.  
There were no significant associations with PEFR, but the study found positive associations for 
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bothersome or more severe asthma symptoms from interquartile range increases in 37 µg/m3 
PM10, 1.45 (95% CI, 1.11-1.90). 
A study by Keeler et al., (2002) involved assessing the indoor air quality using personal 
samples, environmental air quality measurements from central station, twice daily PEFR, 
medication and asthma symptoms four times each year for a two-week duration each season in 
children aged 7-11 years who had moderate to severe asthma. Twenty children participated in 
this Community Action Against Asthma (CAAA) in Detroit Michigan. The results showed 
significance differences in community level exposures.  The southwest Detroit, community 
showed increased levels of PM10 exposure compared to the east (PM10 28.9 ±14.4 for southwest 
compared to PM10 23.8 ±12.1 for the east side).  The increased level in the southwest is thought 
to be due to heavy industrial sites in that area of Detroit.   
Yu et al., (2000) observed 133 children aged 5-13 years of age in Seattle, Washington for 
58 days in relation to ambient air pollution and daily self-reporting of asthma symptoms. The 
children were enrolled into the study during screening for Childhood Asthma Management 
Program (CAMP) study-a randomized clinical trial to evaluate long-term effects of daily anti-
inflammatory medication. Results showed a total of 1,658 daily diary records collected over 580 
days with each child completing a minimal of 28 days and an average of 58 days. The study 
reported an association between increases in PM10 average of 24.7 µg/m³ and asthma symptoms 
in study participants. When the authors considered a lag of 1 day, the relative odds of symptoms, 
was 4.6 (95% CI, 3.6-5.9). However, the diagnosis for the children was not clinically validated 
by a physician. 
In a study involving adults, Penttien et al., (2001) observed asthmatics subjects with a 
positive diagnosis of asthma in Finland who maintained 3 times daily PEFR, symptoms and 
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medication during a six months period. The study proposed to test a hypothesis that particulate 
ambient air might cause alveolar inflammation and subsequently resulting in exhalations 
problems in individuals with pre-existing cardiopulmonary diseases. The results showed that 
daily mean number of particles concentration ranging from PM10 averages of 3.8–73.7 µg/m³ 
was negatively associated with PEFR deviations. 
  Osunsanya et al., (2001) also explored a correlation of day-to-day PEFR deviation in an 
adult populations and air pollution exposure levels and reported a borderline significance 
association of a 19% increase in the rate of 10% decrements in daytime PEFR and PM10. A 
change in PM10 from 10 to 20 µg/m3 was significantly associated with a 14% increase in the rate 
of high scores of shortness of breath and increase use of medicines.  
Desqueyroux et al., (2002) assessed the short-term effects of low-level air pollution on 
respiratory health of adults suffering from moderate to severe asthma. The physicians monitored 
for three months subjects who had a positive diagnosis of asthma, average age 55 years, a 
physician-diagnosed asthma, and on beta 2-agonist inhalation and living in Paris. This study 
showed significant associations between PM10 of winter 24-hr Average 28 ±14 µg/m3 and 
summer 24-hr Average 23 ±9 µg/m3 and asthma attacks in individuals with severe asthma even 
though they were on medication treatment (OR =1.20, 95% CI=1.03 -1.41).   
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2.4.1.2 Chronic Obstructive Pulmonary Disease (COPD) 
Schwartz (1994) examined Medicare admission records for pneumonia and COPD for a period 
of 1986 -1989 among the elderly in Birmingham, Alabama for associations with daily 
monitoring of particles. Significant associations were found between PM10 and hospital 
admissions for pneumonia and COPD. The study found that particulate matter particles were a 
risk factor for admission for pneumonia (for an increase of 100µg/m³ daily relative risk, (RR = 
1.19, 95% C.I, 1.08 - 1.50).  
Harre et al., (1997) followed up a New Zealand cohort of 55 years and older individuals 
with COPD for 3 months to investigate the relationship between air pollution level and 
respiratory symptoms and PEFR. Only subjects residing within 5km radius of the air pollution-
monitoring site were recruited. No associations were reported between PEFR and any pollution 
variables. However, a rise in PM10 concentration equivalent to the inter-quartile range of 35.04 
µg/m3 was associated with an increase in nighttime chest symptoms (RR = 1.38, 95% 1.07- 
1.78).  
In the United Kingdom, Osunsanya et al., (2001) investigated whether the fractions of 
particulate matter of sizes 100 nm could be responsible for changes in health in patients with 
chronic flow obstruction with either asthma or COPD aged 50 years and older living within 5 
miles of an air monitoring site. The study did not show evidence to support the hypothesis.   
2.4.1.3 Upper and lower respiratory symptoms outcomes 
Vichit-Vadakan et al., (2001) examined the responses of three different panels to particulate 
matter in Bangkok, Thailand. Nurses, school children and other adults were asked to report daily 
any upper and lower respiratory symptoms for 3 months. Adult participants lived within 2km of 
the air pollution-monitoring site, did not smoke, and did not have air conditioners at work or 
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home. The results showed high completion rates of diaries, 95% adults, 99% school children and 
99.9% nurses and evidence of an association between upper and lower respiratory symptoms and 
PM10.  An inter-quartile increase of 45 ug/m3 in PM10 was associated with about 50% increase in 
lower respiratory symptoms in highly exposed adults, OR= 1.49 (95% CI= 1.35-1.64).  
In Taiwan, Hwang and Chan (2002) examined a one-year (1998) records of all age 
groups from 50 sites to estimate an association of criteria pollutants and daily numbers of clinic 
visits for lower respiratory tract illness. The study found that people over the age of 65years were 
the most susceptible population to air pollutants and that the air pollutants had greater effect on 
the lower respiratory symptoms for a PM10, 10% increase at lag 0, (OR= .8%, 95% CI= 0.4 - 
1.1).  Brunekreef, Dockery and Krzyzanowski (1995) reported on studies that have shown health 
effects of lung function, acute respiratory symptoms and medication use at levels of PM10 
exposure not exceeding a 24-hr average of 115 µg/m³. 
 
2.4.2 Cardiovascular Disease Outcomes  
Cardiovascular diseases (CVD) rank as the leading cause of death in both men and women and 
among all racial and ethnic groups in the nation (Fried et al., 1991) with more than 2600 deaths 
occurring each day (American Heart Association Statistics, 1999). Some studies have shown that 
individuals who have pre-existing conditions may report more adverse cardiac reactions with 
decrease in air quality. Mann et al., (2002) assessed the increased vulnerability among persons 
admitted with cardiac diseases and showed increases in hospital admissions with an increase in 
concentration of air pollutants for ischemic heart disease (IHD) ICD-9 410-414, myocardial 
infarction (MI) ICD-9 410) and other acute IHD for ICD-9 411.  For a 24-hour mean PM10 
(ug/m3) of 43.7 µg/m³ ±27.7 the percentage increase for IHD admissions was 0.19 (95% CI, -
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0.57-0.95), for MI -0.10 (95% CI, -1.33-1.12) and for other acute IHD 0.36 (95% CI, -0.87-
1.60).  CO and NO2 were consistently associated with the IHD, MI, CHF and other IHD in this 
study. 
Peters et al., (1999) evaluated data of 2,681 men and women who were participants in the 
MONICA Augsburg cohort study for effects of air pollution on heart rate by measuring the 
participants’ resting EKG during the years 1984-1985 and 1987-1988. The larger change in heart 
rate was seen during the air pollution episode of January 1985 that affected the larger part of 
Europe. The most significant change was from the effect of total suspended particulate (70 
ug/m3) episode changes from 5th to 95th percentile on the same day exposure (mean heart rate 
change of 1.61 (95% CI=0.38-2.85). Additionally, on the determinants of Myocardial Onset 
Study of 722 patients Peters et al., (2001), reported that elevated concentration of fine particles in 
the air might transiently elevate the risk of MI onset within a few hours and 1 day after PM2.5 
exposure of 20 ug/m3, OR=1.69 (95% CI, 1.09, 2.02).   
In another study, Peters et al., (2000) tested the hypothesis that people with implanted 
cardiovetter defibrillators experienced potentially life-threatening arrhythmias after air pollution 
episodes. Implantable cardioverter Defibrillators (ICDs) are small electronic devices implanted 
to treat dangerously fast heartbeats that can lead to sudden cardiac arrest.  ICDs are implanted 
under the skin of the chest, near the left collarbone, with wires running to the heart. Implantable 
cardioverter defibrillators monitor deliver electrical shocks to the heart as necessary to eliminate 
abnormal rhythms. For bradycardia, the ICD functions as a pacemaker and sends electric signals 
to the heart. For tachycardia, it sends defibrillation shocks to stop the abnormal rhythm. Among 
the study groups increased risk of cardiac arrhythmias was observed at concentrations of PM10 
and PM2.5 of maximum levels of 62.5 µg/m³ and 53.2 µg/m³, respectively. According to the 
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authors, patients with ten or more interventions of ICD use experienced increased arrhythmias in 
association with nitrogen dioxide, carbon monoxide, black carbon and fine particle mass, 
suggesting that elevated levels of air pollutants are associated with potentially life-threatening 
arrhythmia leading to therapeutic interventions by an ICD. Similarly Robert et al. (2002), in a 
study of healthy adults, showed significant brachial artery vasoconstriction of -0.09± 0.15mm in 
exposure to 150 µg/m³ of the fine particulate versus +0.01 ± 0.18 mm filtered air exposure.  The 
authors reported that these exposures are comparable to urban fine particulate and ozone.   
 
2.4.3 Susceptibility Groups and Air Pollution 
Groups of individuals have been included in studies to ascertain which group of the population is 
most susceptible to PM pollution. According to Arden Pope III (2000) general studies seem to 
suggest that the elderly, young, children and persons with chronic and asthma are more likely to 
be susceptible. Additional studies need to be carried out to assess the relationship of these groups 
to air pollution exposures levels. 
Levy et al., (2002) assessed the contribution five power plants emissions have on 
premature mortality on the subpopulation that includes the less educated, diabetics, and the 
African Americans living in a 50 km geographic radius of Washington DC.  Using estimate 
models the authors concluded that 51% of the deaths from this study area are among individuals 
with less than high school education. The study also concluded that individuals with diabetes, 
and the African Americans had a disproportionate share of cardiovascular hospital admissions 
and asthma emergency respectively, per year.  Such information can help in targeting future air 
pollution exposure assessment or epidemiological efforts to those identified to be more at risk.  
 21
Penttinen et al., (2001) examined an adult asthmatic cohort to assess whether the fine 
particles in ambient air might provoke alveolar inflammation in susceptible individuals with 
preexisting cardiopulmonary diseases. No association was observed between respiratory 
symptoms and medications and the daily mean particles. Roemer et al., (1998) followed 
asthmatic children in a multi-center PEACE in Europe for at least 2 months to assess the acute 
effects of pollution and asthma children using PEFR and symptom medication use diary. The 
study did not show any association between PEFR, respiratory symptoms or bronchodilator use 
and PM10, SO2 and NO2. Conversely, in a study by Koenig et al., (1993) to investigate the 
relationship between fine particulate matter pulmonary function in young children, the study 
indicated that an increase in particulate matter was associated with declines in forced expiratory 
flow volume (FEV) and with forced vital capacity (FVC) by 34 ml and 37ml, respectively, for 
each increase of a corresponding PM2.5 of 20 µg/m³. 
Lastly, von Klot et al., (2002) assessed a panel of 53 adults in Ergrut, Germany by 
comparing their daily health status and medication use and air pollution exposure to PM10, PM2.5, 
and NO2 and SO2 and found that increased inhaled asthma medication use and symptoms of 
asthma were associated with particulate air and gaseous pollution.  A study by Delfino et al., 
(2002) examined the group that was not on anti-inflammatory and showed a risk of symptoms, 
OR 1.19 (95% CI) (0.75-1.88) for an 8 hr- PM10 exposure. 
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2.4.4 Summary of Literature Review 
Particulate matter includes both fine and coarse particles.  Exposure to coarse particles is 
primarily associated with the aggravation of respiratory conditions, such as asthma.  Fine 
particles have been associated with increased hospital admissions and emergency room visits for 
heart and lung disease, increased respiratory disease and symptoms such as asthma, decreased 
lung function, and even premature death.  Groups that are thought to be at greater risk to these 
effects include the elderly, children, individuals with cardiopulmonary disease such as asthma, 
and, the African American and the less educated.   
Increased mortality and morbidity have been linked to periods of high outdoor PM 
concentrations. The PM non-specific chemical agent characteristics make identifying health 
effects associated with its environmental levels a significant issue. In general, PM10 particulates, 
are formed during burning processes and include fly ash from power plants (Levy et al., 2002; 
Aekplakorn et al., 2003), carbon black from automobiles and diesel engines (Jinsart et al., 2002), 
and soot from fireplaces and wood stoves. Jinsart et al., (2002), reported in their study of 
roadside monitoring data that automobile exhaust fumes were the main source of PM emission.  
Aekplakorn et al., (2003) reported that PM10 changes of a 10 µg/m3 increment was associated 
with changes in pulmonary function of children who resided near a coal-fired power plant in 
Thailand.  Exposure to particulate matter may lead to increased use of medication and more 
visits to the doctor or emergency room.  Health effects may include coughing, wheezing, 
shortness of breath, aggravated asthma, lung damage, (including decreased lung function and 
lifelong respiratory disease), HRV and disease of the circulatory system.   
Human and animal patho-physiological studies have shown a mechanism by which the 
body system can incur injury following exposure to air pollutants. Several epidemiology studies 
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have shown a positive correlation between air pollution levels and mortality and morbidity. 
Other acute responses have shown been to occur such as responses of pulmonary lung function. 
Reports, however, continue to show different results and outcomes possibly due to different 
pollutants under investigation, regional differences of pollutant mix.  
In the study using data obtained from the PACCC admission database for Allegheny 
County, the results showed that nearly 50% of the adults are admitted for cardiopulmonary 
causes in Allegheny County.  Additionally, other areas in Allegheny County show consistently 
high levels of air pollution although relatively lower than the USEPA standard. Other studies of 
Allegheny County residents have reported an association between air pollution and 
cardiopulmonary disease morbidity and mortality in Pittsburgh (Muzumdar and Sussman 1983; 
Schwartz 2000; Chock et al., 2000). The study results of the PACCC data and previous studies in 
the region were of interest to us as this established an antecedent to a longitudinal study targeting 
the elederly in Allegheny County. 
Many of the ecological studies that have shown a correlation between air pollution and 
disease outcome have used exposure level from central stationary air monitoring sites.  Very few 
studies have apportioned individual exposures. All these factors need further exploration to 
improve on air pollution exposure studies and to inform the local, state and regional entities with 
concrete evidence of such research outcomes.  
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Table 1: Summary of morbidity studies of low-level particulate matter: 1996-2004  
 
 
 
Author 
(Country) 
Level of Exposure End Point Risk Estimate  
Devlin et al., (2003) 
 (US) 
PM2.5: Individual 24-hr 
Average 21.2-80 µg/m3
 
Decrease in heart rate 
variability in elderly 
60-80yrs 
 
35.7% Decrement in Heart  
Rate Variability 
Ghio et al., (2000)  
(US) 
PM2.5:  24-hr Average  
23-31µg/m3 
 
Lung inflammation 
and hypoxia in 
healthy adults ≥27yrs 
 
8.44±1.99 in Bronchial 
Neutrophils and 4.2±1.69 
Alveolar Fraction  
Jedrychowski et al., 
(1999)  
(Poland) 
Suspended PM: 24-hr 
Average 52.6 ± 53.98µg/m3 
 
Pulmonary function 
retardation in pre-
adolescent 9yr-olds 
 
OR 2.15 (1.25-3.69) 
 
Zemp et al., (1999)  
(Switzerland) 
PM10:  24-hr Average  
10.1-33.4 µg/m3  
 
Respiratory 
symptoms in non-
smokers in Adults 
18-60yrs 
 
OR 1.48 (1.23-1.78) 
(Breathless in day) for an 
increase in 10µg/m3
  
Pope et al., (2004) 
 (US) 
PM2.5:   24-hr Average  
18.9 ± 13.4µg/m3
 
CVD, HRV 
blood markers &  
inflammation in 
adults 54-89yrs 
 
35 (SE=8) msec decline in SD of 
all normal R-R intervals 
HRV measured as SDNN for an 
increase in 100 µg/m3
Boezen et al., (1998) 
(Netherlands) 
PM10: Urban 24-hr Average 
41.55 (12.1-112.7).  Rural 
24-hr Average  
44.1(7.9-242.2) 
 
Upper respiratory 
symptoms (URS) 
 
 
Lower respiratory 
symptoms (LRS)  
in adults 48-73yrs 
 
OR 0.77 (0.62-0.96) (URS) for 
≤5% Peak expiratory flow rate 
decrease 
 
OR 1.10 (0.81-1.50) (LRS) for 
≤5% Peak expiratory flow rate 
decrease 
Koken et al., (2003)  
(US) 
PM10: 24-hr Average  
24.2± 6.25 
 
CVD arrhythmias in 
adults ≥65yrs 
-17.6% (-26.7- -7.5)  
8.9 (-0.34-18.93)  
% Change in Hospital 
admissions 
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Table 1 (Cont’d) 
 
 
Author 
(Country) 
Level of Exposure End Point Risk Estimate  
Delfino (1998) 
 (US) 
PM10: 24-hr Average  
25 µg/m3
Respiratory 
symptoms in children 
OR 1.50 (0.8-2.8) 90th percentile 
 
 
Hernandez- Cadena 
et al., (2000) 
(Mexico) 
 
PM10: 24-hr Average  
34.46 µg/m3
Respiratory diseases  
in children <15yrs 
OR 4.97 (0.77-9.13) for an 
increase in 20µg/m3
Hwang and Chan 
(2002)  
(Taiwan) 
 
PM10: 24-hr Average  
58.9 ± 14 µg/m3
 
Lower respiratory 
tract illness in adults 
≥65yrs 
RR 1.8 (1.4-2.2) for increase in 
10% 
 
Ibald-Mulli et al., 
(2004) 
(Germany) 
PM2.5: 24-hr Average  
12.7-20 µg/m3 
(±39.8-118 µg/m3 for  
3 cities) 
Blood Pressure 
increase 
heart in adults 40-
84yrs 
 
β -0.27 (-0.5-.03) for increase in 
10 µg/m3
Keeler et al., (2002) 
 (US) 
PM10: 24-hr Average 28.9 ± 
14.4 µg/m3 (west Detroit)
23.8 ± 12.1 µg/m3 (east 
Detroit)
PM2.5: 24-hr Average 17.0 ± 
9.3 µg/m3 (west)
15.5 ± 9.0 µg/m3 (east) 
 
Respiratory disease  
in children 
N/A 
Liao et al., (1999) 
US 
PM2.5: 24-hr Average          
≥ 15 µg/ m3
CVD, HRV in adults  
65-84yrs 
OR 3.08 (1.43-6.59) 
Mc Connell et al., 
(1999) 
 (US) 
PM10:  24-hr Average 
 34.8 µg/m3
 
Respiratory 
symptoms 
bronchitis 
in children 
 
OR 1.4 (1.1-1.4) for increase in 
10 µg/m3
 
Pentinen et al., 
(2001) 
 (Finland) 
PM10: Median 13.5 µg/m3 
Range 3.8-73.7 µg/m3 
PM2.5: Median 8.4 µg/m3 
Range 2.4-38.3 µg/m3 
 
Respiratory 
symptoms PEF and 
asthma in adults  
mean age 53yrs 
At lag 0  Symptoms β 0.001 
(SEM 0.04) 
Peters et al., (2001)  
(US) 
PM10: 24-hr Average  
19.4 ± 9.4 µg/m3   
 
CVD in adults mean 
age 61.6 ± 13.4yrs 
 
OR 1.69 (1.13-2.34) for increase 
in 20 µg/m3
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Table 1 (Cont’d) 
 
 
Author 
(Country) 
Level of Exposure End Point Risk Estimate  
Slaughter et al., 
(2003) 
 (US) 
PM10: 21.0 µg/m3 (75th 
Percentile =29.3 µg/m3) 
Respiratory 
symptoms asthma  
attacks in children 
 
OR 1.12 (1.04-1.22) for increase 
 in 10 µg/m3
 
von Klot et al., 
(2001)  
(Germany) 
PM10: 24-hr Average 
 45.4 µg/m3  
PM2.5: 24-hr Average  
10.3 µg/m3  
 
Respiratory 
symptoms in adults  
mean age 59yrs 
 
OR 1.01 (.95-1.06) for increase 
in 1 IQR of 12 
 
Yu et al., (2000)  
(US) 
 
 PM10: 24-hr Average  
24.7 µg/m3  
Respiratory 
symptoms asthma  
in children mean age 
8.6 ± 2.1yrs 
 
OR18% (5-33) for increase  
in 10 µg/m3
 
Peters et al., (2000) 
(US) 
PM10: 24-hr Average  
19.3 µg/m3   
 
CVD arrhythmias in 
adults mean age 
62.2yrs 
OR 0.95 (0.59-1.54) for Same 
day defibrillation discharge for 1 
event 
 
Desqueyroux et al., 
(2002) 
(France) 
PM10 Winter 24-hr Average 
28 ±14 µg/m3  
Summer 24-hr Average  
23 ±9 µg/m3  
Respiratory 
symptoms asthma in 
adults mean age 
55yrs 
 
OR 1.41 (1.16-1.7) for increase 
in 10 µg/m3
Delfino et al., (2002) 
(US) 
PM10: 24-hr Average  
7-32 µg/m3   
Respiratory  disease 
asthma in children 
OR 1.35 (0.82-2.2) v/s 
OR 0.80 (0.24-2.69) for Lag 0 
vs.90th percentile 
 
de Hartog et al., 
(2003) 
(Amsterdam 
Finland 
Germany) 
PM2.5: Average 24-hr  
12.8-23.4 µg/m3   
 
PM10: Average 24-hr  
19.6-36.5 µg/m3   
 
 
Cardio-respiratory 
symptoms  
in elderly 
OR 1.12 (1.02-1.24) 
 
 
OR 1.09  (0.97-1.22) for 
increase in 10 µg/m3
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  This project will test the following study hypothesis: 
Hypothesis 1. Increased PM10 changes of 10 µg/m³ will be linked to cardiopulmonary 
symptoms in the most susceptible adult populations. 
 
Hypothesis 2. The peak expiratory flow rates will decrease by 10% from the mean 
individual peak flow rate when PM10 levels increase by levels of 10 µg/m³ in individuals 
with pre-existing cardiopulmonary conditions  
 
Hypothesis 3. Individuals with pre-existing cardiopulmonary conditions who are not on 
anti-inflammatory medication will experience increased cardiopulmonary symptoms 
when PM10 increase by levels of 10 µg/m³. 
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3.0 RESEARCH DESIGN AND METHODOLOGY 
 
The goal of the Allegheny County short-term air pollution effects (SHAPE) study was to 
determine if there is an association between ambient air exposures and the incidence of short-
term cardiopulmonary responses in susceptible adult individuals aged between 50–79 years old.  
Inhalable ambient particulate matter ≤10 um in aerodynamic diameter (PM10) from a selected 
Allegheny County Health Department (ACHD) Division of Air Quality monitoring site was used 
in the analysis.  The study was carried out in a portion of Allegheny County, PA, which is in the 
south west of Pennsylvania (Figure 1).   
3.1 Rationale of Selection of the Study 
The SHAPE study focused on effects of air pollution on residents in the southwest part of the 
county because of the major stationary polluting sources that are still operating in the area, 
including a major coal fired coke plant. The selection of the study area was additionally 
influenced by a concurrent evaluation of the PACCC admission data of Allegheny County, 1995-
2000 which showed that the local health facility in the south west of the county, had the second 
largest number of admissions among the elderly aged ≥65 years old compared to other facilities.  
The facility also had the highest number of admissions from surrounding zip codes areas, an 
indication that the communities utilize mainly their local health facility for tertiary health care.  
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 Figure 1: A Map of Allegheny County study area showing boundaries to other counties 
 
 
 
Furthermore, the analysis of the PACCC admission data of years 1995-2000 showed that 
a total of 588,678 hospital admissions were of the elderly aged ≥65 years old admitted to the 
Allegheny County health facilities that exclude nursing homes, hospice and long-term facilities.  
Forty-three percent (252,612) of these admissions were due to cardiopulmonary primary 
conditions, ICD-9 codes 390-519. Over 60% of the elderly were aged less than 80 years. More 
females were admitted to the hospitals compared to the males (Table 2). The mean length of 
hospital stay was 7 days (STD±7.592). Perez-Hoyos et al., (2000) reported an average length of 
stay in the hospital emergency room of 5.21 hours for asthma and 6.32 hours for COPD and 
longer among study subjects. The authors caution air pollution studies that examine hospital 
admission data and the lag effects of air pollution. The date of admission can be erroneous for a 
subject who is admitted late at night to the ER and then later on admitted to the hospital in the 
 30
early hours of the following day. When the data was examined further for patterns of discharge 
diagnosis (primary diagnosis), among the 252,612 hospital admissions for the six-year study 
period the results showed that the majority of the discharge diagnoses were for cardiovascular 
diseases (72.7%) and 27.3% for respiratory disease causes (Table 3). Ischemic heart disease 
(IHD) conditions accounted for 21.81% of the admissions. These IHD include acute myocardial 
infarction, and angina pectoris and other forms of IHD. Twenty-five percent (25%) of the 
admissions were due to other forms of heart disease that included heart failure (15%), and 
cardiac arrhythmias (8%).  Pneumonia and influenza accounted for the highest number of 
admissions among respiratory diseases conditions (10.50%), followed by COPD (9.28%).  
Forty nine percent of the individuals were admitted multiple times during the 6–year 
study period 1995- 2000. The discharge diagnosis of each individual’s first-ever admission to a 
health facility was evaluated for both the individuals admitted multiple times and those admitted 
only one.  Tables 4 shows the rates of admissions by ICD Codes of the primary diagnosis. For 
those admitted more than one time we show the diagnoses obtained at their ever first admission 
during the study period. The results show that individuals admitted more than one time had 
frequently a diagnosis of acute conditions compared to those admitted only one time. For 
example the rate of admission for IHD was 6,335 /100,000 for the multiple admissions group 
compared to 5,285 among the group admitted only one time. The one-time admission group was 
frequently admitted for chronic causes such as disease of the veins and lymphatic circulation 
1363/100,000 compared to 797/100,000 among the multiple admissions group; pneumoconiosis 
and other lung diseases 844/100,000 compared to 444/100,000 among those admitted multiple 
times. The rates were calculated using the 2000 U.S. Census Bureau population data for the 
Allegheny County age group ≥65 years.  
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Further, the PACCC data was examined for the admitting diagnosis of those admitted 
multiple times (an admitting diagnosis is a diagnosis assigned when an individual first arrives to 
a hospital). There were a total of 463 specific ICD-9 codes assigned to the cohort. The results 
showed that 16% of the admitting diagnoses were for heart failure (ICD code 428), 11% for 
unspecified respiratory symptoms (ICD code, 786), 8% for pneumonia and other unspecified 
organisms (ICD code, 486), 7% for cardiac dysrhythmias (ICD code, 427), 5% for acute 
myocardial infraction and other acute and subacute form of ischemic heart disease (ICD code, 
411 and ICD code 410) respectively, 4% for chronic bronchitis (ICD code, 491).  
The admission rates of this age group ≥65 years old remained relatively constant across 
the age groups. Higher rates for the age group ≥75 increased slightly each year. The rates of 
admissions were higher in females compared to males during the entire study (Table 5). The 
admission rates across ethnicity groups were consistent with the different population groups in 
Allegheny County where more whites than other races were admitted to the hospitals. 
 An analysis of the discharge status of the multiple admissions showed that more than 
half (55%) of this age group is discharged home for self-care following hospitalization (Table 6). 
These results also showed that this group of patients is discharged home mostly for independent 
living. The premise is that these individuals live actively in their communities and may endure 
environmental exposures equally as much as any other age group but their susceptibility to the 
environmental exposures may be higher (Goldberg et al., 2000; Zanobetti et al., 2000; Delfino et 
al., 1997; Pope et al., 1999; Liao et al., 1999; Gold et al., 2000; Stone et al., 1999). This requires 
regional longitudinal investigation. 
Furthermore, during the PACCC data evaluation for the period (1995-2000) the local 
county air pollution showed a maximum 24-hr PM10 of 490 µg/m3 and average 24-hour PM10 of 
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28 µg/m3.  In general, the pollution levels have declined with the average 24-hour PM10 of 31 
µg/m3 observed in year1995 to 27 µg/m3 observed in year 2000 (Table 7). The PM10 averages for 
both the mean and the maximum showed high peak levels during the summer and fall months 
(Figure 2). The results also showed that the air pollution is improving over time. For example the 
24-hr average PM10 was 30 µg/m3 in 1995 and 25 µg/m3 in year 2000 (Table 7, Figure 2). 
Additionally, the air pollution level showed that Lincoln and Liberty Borough exhibited high 
levels of particulate matter emissions compared to other continuous monitoring sites (Lincoln 
maximum 101 µg/m3, average 40 µg/m3; and Liberty maximum 74 µg/m3, average 30 µg/m3). 
These two sites were located to monitor compliance of the industrial plants in the southwest of 
Allegheny County.   
 For additional analysis, we stratified the data into admission category, that is, 
individuals who were admitted only one time and individuals who were admitted more than one 
time but only considering the first time an individual was ever admitted during the study period. 
A logistic regression using the SAS system was carried out to assess the effect of the 24-hr 
average PM10, and confounding meteorological variables of dew point average, mean 
temperature, mean relative humidity, pressure, and also effects of seasonality, day of the week 
and age group. The results showed highly significant association between PM10 (p<.0001) and 
the type of admission of the elderly individuals and a very narrow margin of risk (OR =1.002, 
95% CI= 1.002 – 1.003).  However, seasonality, pressure and age group also had high significant 
effect (p<.0001) on type of admission.  
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Table 2: Comparison of Admission frequency by age group and gender: 1995-2000 
 
 
 
Multiple Admissions 
 
One-time Admission    
* Age Group 
  
  
Males Females Total Males Females Total 
 
65-69 
5,733 5,001 10,734 5,435 5,232 10,667 
 % within Gender 22.7% 16.1% 19.0% 
 
22.9% 15.0% 18.2% 
  
70-74 
6,409 6,292 12,701 
 
5,746 6,529 12,275 
% within Gender  25.4% 20.2% 22.5% 
 
24.2% 18.7% 20.9% 
  
75-79 
5,925 7,124 13,049 
 
5,255 7,333 12,588 
% within Gender  23.4% 22.9% 23.1% 
 
22.2% 21.0% 21.4% 
  
80+ 
7,204 12,703 19,907 
 
7,287 15,884 23,171 
 % within Gender 28.5% 40.8% 35.3% 
 
30.7% 45.4% 39.5% 
 
Total 
25,271 31,120 56,391 23,723 34,978 58,701 
 
* Mean age for multiple admissions is 76.77. Mean age for one time admission is 77.54 
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Table 3: Distribution of admission for the elderly by primary diagnosis: 1995-2000 
 
 
Cause of Admission ICD Code N % 
DISEASE OF THE CIRCULATORY SYSTEM  390-459   
Acute and Chronic Rheumatic Heart Disease 390-392 15 0.00 
Chronic Rheumatic Heart Disease 393-398 2,012 0.80 
Disease of Mitral Valve 394 140 0.06 
Disease of Aortic Valve 395 36 0.01 
Disease of Mitral and Aortic Valve 396 586 0.23 
Disease of other Endocardial Structure 397 18 0.00 
Other Rheumatic Heart Disease 393, 398 1,232 0.50 
Hypertensive Diseases 401-405 5,072 2.01 
Essential Hypertension 401 1,255 0.50 
Hypertensive Heart Disease 402 2,278 0.90 
Hypertensive renal Disease 403 809 0.32 
Hypertensive heart and renal Disease 404 692 0.27 
Secondary Hypertension 405 38 0.02 
Ischemic Heart Disease 410-414 55,103 21.81 
Acute Myocardial Infarction 410 20,424 8.09 
Other Acute and Subacute Form of Ischemic Heart 
Disease 
411 3,394 1.34 
Old Myocardial Infarction 412 3 0.00 
Angina Pectoris 413 1,038 0.41 
Other Forms of Ischemic Heart Disease 414 30,244 11.97 
Disease of the Pulmonary Circulation 415-417 2,164 0.85 
Acute pulmonary heart disease 415 1,858 0.73 
Chronic pulmonary heart disease 416 303 0.12 
Disease of other pulmonary circulation 417 3 0.00 
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Table 3 (Cont’d) 
 
Cause of Admission ICD Code N % 
Other Forms of Heart Disease  420-429 63,802 25.27 
Acute pericarditis and pericardium diseases 420, 423 470 0.19 
Acute and subacute endocarditis  421 277 0.11 
Other disease of endocardium 424 1,490 0.59 
Cardiomyopathy 425 611 0.24 
Conduction disorders 426 1,538 0.61 
Cardiac dysrhythmias 427 20,501 8.12 
Heart failure 428 38,740 15.34 
Other and ill-defined heart disease 422,429 175 0.06 
Cerebrovascular Diseases 430-438 35,341 13.99 
Subarachnoid hemorrhage 430 398 0.16 
Intracerebral hemorrhage 431 2,110 0.84 
Other and unspecified intracranial hemorrhage 432 509 0.20 
Occlusion and stenosis of precerebral arteries 433 6,526 2.58 
Occlusion of cerebral arteries 434 12,607 4.99 
Transient cerebral ischemia 435 8,261 3.27 
Acute but ill-defined cerebrovascular disease 436 3,853 1.53 
Other ill-defined cerebrovascular disease 437 901 0.36 
Late effects of cerebrovascular disease 438 176 0.07 
Disease of Arteries, Arterioles and Capillaries 440-448 10,780 4.26 
Atherosclerosis 440 4,290 1.70 
Aortic aneurysm 441 2,656 1.05 
Other aneurysm 442 295 0.12 
Other peripheral vascular disease 443 1,175 0.47 
Arterial embolism and thrombosis 444 1,558 0.62 
Polyarteritis nodosa and allied conditions 446 240 0.10 
Other disorders of arteries and arterioles  447 545 0.22 
Disease of capillaries 448 21 0.00 
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Table 3 (Cont’d) 
 
 
Cause of Admission ICD Code N % 
Disease of Veins, Lymphatic and Others Diseases of  
Circulatory System 
451-459 9,060 3.59 
Phlebitis and thrombophlebitis 451 728 0.29 
Other venous embolism and thrombosis 452-453 4,197 1.66 
Varicose veins 454-456 1,179 0.47 
Hypotension 458 2,278 0.90 
Other disorders of circulatory system 457, 459 678 0.27 
DISEASE OF THE RESPIRATORY SYSTEM  460-519   
Acute Respiratory Infection 460-466 2,242 0.89 
Acute bronchitis and bronchiolitis 466 1,941 0.77 
Other acute respiratory infections 460-465 301 0.12 
Other Diseases of Upper Respiratory Tract 470-478 240 0.10 
Pneumonia and Influenza 480-487 26,521 10.50 
Viral pneumonia 480 188 0.07 
Pneumococcal pneumonia 481 1,002 0.40 
Other bacterial pneumonia 482 5,217 2.07 
Bronchopneumonia, organism unspecified 485 290 0.11 
Pneumonia, other, unspecified 483, 484, 486 19,598 7.76 
Influenza 487 226 0.09 
Chronic Obstructive Pulmonary Disease and Allied 
Conditions 
 
490- 496 23,449 9.28 
Bronchitis, not specified as acute or chronic 490 376 0.15 
Chronic bronchitis 491 16,842 6.67 
Emphysema 492 849 0.34 
Asthma 493 3109 1.23 
Bronchiectasis 494 192 0.08 
Extrinsic allergic alveolitis and other chronic airways 
obstruction 
 
495-496 2,081 0.82 
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Table 3 (Cont’d) 
 
 
Cause of Admission ICD Code N % 
Pneumoconiosis and Other Lung Disease Due to External 
Agents 
500-508 7,529 2.98 
Coalworker’s pneumoconiosis  500 23 0.01 
Asbestosis and pneumoconiosis due to other silica or silicates 501-502 35 0.02 
Pneumoconiosis, other and unspecified 503-505 5 0.00 
Pneumonitis due to solids and liquids 507 7,395 2.93 
Respiratory conditions due to other and unspecified external agents 506, 508 71 0.02 
Other Disease of the Respiratory System 510-519 9,282 3.67 
Emphysema 510 171 0.07 
Pleurisy 511 1,541 0.61 
Pneumothorax 512 590 0.23 
Abscess of lung and mediastinum 513 123 0.05 
Pulmonary congestion and hypostasis 514 147 0.06 
Postinflammatory pulmonary fibrosis 515 428 0.17 
Other alveolar and parietoalveolar pneumopathy 516 333 0.13 
Other disease of the lung 517-518 5,751 2.28 
Other disease of respiratory system 519 198 0.08 
Total Admissions 390-519 252,612 100 
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Table 4: Rates of admission by discharge diagnosis among the elderly admitted multiple 
and one-time 1995-2000 
 
 
Diagnosis and Diagnostic Codes 
* First ever admission of 
multiple admissions 
**One time admission 
Primary Diagnosis 
 
ICD Code 
 
N 
 
% 
 
Rates*** 
 
N 
 
% 
 
Rates*** 
DISEASES OF 
CIRCULATORY 
SYSTEM 
       
Acute and Chronic 
Rheumatic Heart Disease 
390-392 1 0  2 0  
Chronic Rheumatic Heart 
Disease 
393-398 381 0.65 166.80 324 0.55 142.72 
Disease of Mitral Valve 394 30 0.05 13.13 31 0.05 13.57 
Disease of Aortic Valve 395 7 0.01 3.06 11 0.02 4.82 
Disease of Mitral and Aortic 
Valve 
396 130 0.22 56.91 150 0.26 66.55 
Disease of other 
Endocardial Structure 
397 3 0 1.31 5 0.01 2.19 
Other Rheumatic Heart 
Disease 
393, 398 211 0.37 92.38 127 0.21 55.60 
Hypertensive Diseases 401-405 1,077 1.92 471.51 1,090 1.86 478.95 
Essential Hypertension 401 303 0.54 132.65 473 0.81 207.95 
Hypertensive Heart Disease 402 496 0.88 217.15 393 0.67 172.49 
Hypertensive renal Disease 403 167 0.3 73.11 136 0.23 59.98 
Hypertensive heart and 
renal Disease 
404 102 0.18 44.66 80 0.14 35.02 
Secondary Hypertension 405 9 0.02 3.94 8 0.01 3.50 
Ischemic Heart Disease 410-414 14,472 25.64 6,335.81 12,014 20.56 5,285.09 
Acute Myocardial Infarction 410 6,012 10.64 2,632.04 4,756 8.16 2,098.36 
Other Acute and Subacute 
Form of Ischemic Heart 
Disease 
411 1,225 2.17 536.30 682 1.17 300.33 
Old Myocardial Infarction 412 1 0 0.44 0 0 0.00 
Angina Pectoris 413 332 0.59 145.35 314 0.54 138.34 
Other Forms of Ischemic 
Heart Disease 
414 6,902 12.24 3,021.68 6,262 10.69 2,748.06 
*The first-ever admission shows the first diagnosis among individuals admitted multiple times during the six years 
of study. ** Total number of people admitted only one time during the six years of study. Percent is calculated from 
the total admissions.  ***Rate per 100,000 Populations, US Census Bureau 2000 
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 Table 4 (Cont’d) 
 
 
Diagnosis and Diagnostic Codes 
* First ever admission of 
multiple admissions 
**One time admission 
Primary Diagnosis 
 
ICD Codes 
 
N 
 
% 
 
Rates*** 
 
N 
 
% 
 
Rates*** 
Disease of the Pulmonary 
Circulation 
415-417 416 .75 182.12 768 1.32 338.42 
Acute pulmonary heart 
disease 
415 363 0.65 158.92 700 1.2 308.21 
Chronic pulmonary heart 
disease 
416 52 0.1 22.77 68 0.12 30.21 
Disease of other 
pulmonary circulation 
417 1 0 0.44 0 0 0.00 
Other Forms of Heart 
Disease  
420-429 13,365 23.72 5,851.17 11,746 20.11 5,170.39 
Acute pericarditis and 
pericardium diseases 
420, 423 101 0.18 44.22 161 0.27 70.92 
Acute and subacute 
endocarditis  
421 49 0.08 21.45 62 0.11 27.14 
Other disease of 
endocardium 
424 336 0.6 147.10 409 0.7 179.50 
Cardiomyopathy 425 118 0.2 51.66 111 0.21 53.85 
Conduction disorders 426 394 0.71 172.49 587 1 256.99 
Cardiac dysrhythmias 427 4,877 8.66 2,135.14 5,270 9.01 2,315.95 
Heart failure 428 7,463 13.24 3,267.28 5,105 8.76 2,252.03 
Other and ill-defined heart 
disease 
422,429 27 0.05 11.82 31 0.05 14.01 
Cerebrovascular 
Diseases 
430-438 8,816 15.63 3,859.62 10,633 18.2 4,681.37 
Subarachnoid hemorrhage 430 75 0.13 32.83 169 0.29 75.74 
Intracerebral hemorrhage 431 409 0.73 179.06 828 1.42 364.69 
Other and unspecified 
intracranial hemorrhage 
432 95 0.17 41.59 187 0.32 81.87 
Occlusion and stenosis of 
precerebral arteries 
433 1,979 3.5 866.40 1,722 2.94 756.08 
Occlusion of cerebral 
arteries 
434 3,278 5.82 1,435.10 3,846 6.6 1,697.34 
Transient cerebral 
ischemia 
435 2,072 3.68 907.12 2,602 4.44 1,141.34 
Acute but ill-defined 
cerebrovascular disease 
436 708 1.26 309.96 975 1.67 430.36 
*The first-ever admission shows the first diagnosis among individuals admitted multiple times during the six years 
of study. ** Total number of people admitted only one time during the six years of study. Percent is calculated from 
the total admissions.  ***Rate per 100,000 Populations, US Census Bureau 2000 
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Table 4 (Cont’d) 
 
Diagnosis and Diagnostic Codes 
* First ever admission of 
multiple admissions 
**One time admission 
Primary Diagnosis 
 
ICD Codes 
 
N 
 
% 
 
Rates*** 
 
N 
 
% 
 
Rates*** 
Other ill-defined 
cerebrovascular disease 
437 178 0.31 77.93 275 0.47 121.27 
Late effects of 
cerebrovascular disease 
438 22 0.03 9.63 29 0.05 12.70 
Disease of Arteries, 
Arterioles and 
Capillaries 
440-448 2,434 4.27 1,065.60 2,681 4.59 1,178.11 
Atherosclerosis 440 965 1.72 422.47 795 1.36 349.36 
Aortic aneurysm 441 537 0.95 235.10 1,059 1.81 464.94 
Other aneurysm 442 67 0.12 29.33 63 0.11 28.02 
Other peripheral vascular 
disease 
443 269 0.47 117.77 190 0.32 83.18 
Arterial embolism and 
thrombosis 
444 393 0.71 172.05 377 0.65 166.36 
Polyarteritis nodosa and 
allied conditions 
446 63 0.11 27.58 74 0.13 32.40 
Other disorders of arteries 
and arterioles  
447 135 0.19 59.10 116 0.2 50.78 
Disease of capillaries 448 5 0 2.19 7 0.01 3.06 
Disease of Veins, 
Lymphatic and Others 
Diseases of  Circulatory 
System 
451-459 1,817 3.2 795.48 3,104 5.3 1,363.30 
Phlebitis and 
thrombophlebitis 
451 184 0.32 80.55 282 0.48 124.33 
Other venous embolism and 
thrombosis 
452-453 822 1.46 359.87 1,589 2.72 697.41 
Varicose veins 454-456 256 0.45 112.08 420 0.71 184.31 
Hypotension 458 427 0.75 186.94 620 1.06 272.75 
Other disorders of 
circulatory system 
457, 459 128 0.22 56.04 193 0.33 84.49 
DISEASE OF THE RESPIRATORY 
SYSTEM  
      
Acute Respiratory 
Infection 
460-466 576 1.05 252.17 765 1.29 336.23 
Acute bronchitis and 
bronchiolitis 
466 498 0.89 218.02 651 1.11 286.32 
Other acute respiratory 
infections 
460-465 78 0.16 34.15 114 0.18 49.91 
Other Diseases of Upper 
Respiratory Tract 
470-478 48 0.07 21.01 97 <1 42.47 
*The first-ever admission shows the first diagnosis among individuals admitted multiple times during the six years 
of study. ** Total number of people admitted only one time during the six years of study. Percent is calculated from 
the total admissions.  ***Rate per 100,000 Populations, US Census Bureau 2000 
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 Table 4 (Cont’d) 
 
 
Diagnosis and Diagnostic Codes 
* First ever admission of 
multiple admissions 
**One time admission 
Primary Diagnosis 
 
ICD 
Codes 
 
N 
 
% 
 
Rates*** 
 
n 
 
% 
 
Rates*** 
Pneumonia and influenza 480-487 5,580 9.89 2,442.91 7,485 12.85 3,304.06 
Viral pneumonia 480 51 0.1 22.33 59 0.1 25.83 
Pneumococcal pneumonia 481 256 0.45 112.08 316 0.54 138.78 
Other bacterial pneumonia 482 1,121 1.98 490.77 1,302 2.25 577.46 
Bronchopneumonia, 
organism unspecified 
485 72 0.13 31.52 77 0.13 34.59 
Pneumonia, other, 
unspecified 
483,484, 
486 
4,041 7.16 1769.14 5,606 9.66 2,483.63 
Influenza 487 39 0.07 17.07 100 0.17 43.78 
Chronic Obstructive 
Pulmonary Disease and 
Allied Conditions 
490- 496 4,981 9.72 2,180.67 3,667 6.3 1,615.91 
Bronchitis, not specified as 
acute or chronic 
490 108 0.19 47.28 111 0.19 48.60 
Chronic bronchitis 491 3,277 5.81 1,434.66 2,356 4.04 1,037.14 
Emphysema 492 231 0.41 101.13 121 0.21 53.41 
Asthma 493 789 1.39 345.42 734 1.26 323.09 
Bronchiectasis 494 41 0.97 17.95 28 0.05 12.26 
Extrinsic allergic alveolitis 
and other chronic airways 
obstruction 
495-496 535 0.95 234.22 317 0.55 141.41 
Pneumoconiosis and Other 
Lung Disease Due to 
External Agents 
500-508 939 1.65 411.09 1,916 3.28 844.51 
Coalworker's 
pneumoconiosis  
500 5 0.01 2.19 8 0.01 3.50 
Asbestosis and 
pneumoconiosis due to other 
silica or silicates 
501-502 12 0.02 5.25 6 0.01 2.63 
Pneumoconiosis, other and 
unspecified 
503-505 2 0 0.88 2 0 0.88 
Pneumonitis due to solids 
and liquids 
507 907 1.6 397.08 1,877 3.22 827.44 
*The first-ever admission shows the first diagnosis among individuals admitted multiple times during the six years 
of study. ** Total number of people admitted only one time during the six years of study. Percent is calculated from 
the total admissions.  ***Rate per 100,000 Populations, US Census Bureau 2000 
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Table 4 (Cont’d) 
 
 
Diagnosis and Diagnostic Codes 
* First ever admission of 
multiple admissions 
**One time admission 
Primary Diagnosis 
 
ICD 
Codes 
 
N 
 
% 
 
Rates*** 
 
n 
 
% 
 
Rates*** 
Respiratory conditions due 
to other and unspecified 
external agents 
506, 508 13 0.02 5.69 23 0.04 10.07 
Other Disease of the 
Respiratory System 
510-519 1,487 2.58 651.01 2,081 3.58 919.81 
Emphysema 510 30 0.06 13.13 52 0.09 22.77 
Pleurisy 511 221 0.39 96.75 375 0.64 165.05 
Pneumothorax 512 159 0.28 69.61 166 0.28 73.11 
Abscess of lung and 
mediastinum 
513 18 0.03 7.88 25 0.04 10.94 
Pulmonary congestion and 
hypostasis 
514 38 0.07 16.64 24 0.04 10.51 
Postinflammatory pulmonary 
fibrosis 
515 80 0.14 35.02 103 0.18 45.09 
Other alveolar and 
parietoalveolar pneumopathy 
516 68 0.12 29.77 80 0.14 36.34 
Other disease of the lung 517-518 837 1.49 366.44 1,217 2.1 538.93 
Other disease of respiratory 
system 
519 36  15.76 39 0.07 17.07 
Total Admissions 
 
390-519 
 
56,391 
 
100 
 
24,687.85 
 
58,373 
 
100 
 
25,700.91 
 
*The first-ever admission shows the first diagnosis among individuals admitted multiple times during the six years 
of study. ** Total number of people admitted only one time during the six years of study. Percent is calculated from 
the total admissions.  ***Rate per 100,000 Populations, US Census Bureau 2000 
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Table 5: Rates of admissions of elderly in Allegheny County for cardiopulmonary causes: 
1995-2000 
  
 
Year of 
Admission  
*Rates of 
Admissions 
Persons 65-74 
Years 
 
Rates (N) 
*Rates of 
Admissions 
Persons ≥75 Years 
 
 
Rates (N) 
*Rates of 
Admissions Male 
 
 
 
Rates (N) 
*Rates of 
Admissions 
Female 
 
 
Rates (N) 
1995 
 
50.18 (11,872) 72.33 (17,112) 52.79 (12,490) 
 
69.71 (16,493) 
 
1996 
 
49.39 (11,633) 73.19 (17,238) 53.84 (12,682) 69.16 (16,289) 
 
1997 
 
47.63 (11,047) 75.04 (17,404) 52.61 (12,201) 70.06 (16,250) 
 
1998 
 
44.24 (10,188) 
 
76.32 (17,574) 52.83 (12,165) 69.44 (15,989) 
 
1999 
 
45.16 (10,228) 
 
81.66 (18,494) 54.68 (12,383) 72.14 (16,337) 
 
2000 42.18 (9,635) 
 
81.52 (18,620) 53.04 (12,114) 70.66 (16,141) 
 
*Rates of admissions are expressed for population per 1,000. N= number of admissions. The denominator is from 
the Allegheny County Population Estimates for 1995-2000 and 2000 US Census Data for Allegheny County. The 
rates of hospital admissions among Persons 65-74 years group show a decline from 1995-2000, and an increase 
among Persons ≥75 Years.   
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Table 6: Discharge status of elderly admitted multiple times: 1995-2000 
 
 
Discharge Status Frequency Percent 
 
Discharged home-self care 105,817 54.57 
Transferred to another General Hospital 9,935 5.12 
Discharged to a skilled nursing facility 27,356 14.11 
Discharged to an intermediate care facility 2,111 1.09 
Discharged to another type of inpatient care 13,451 6.94 
Discharged home under Home service care services 26,051 13.43 
Expired 8,666 4.47 
Other discharge status 520 0.27 
Total 193,907 100 
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Table 7:  Mean and maximum PM10 µg/m3 averages for Allegheny County: 1995-2000 
 
 
 
YEAR 
 
 
 
24-hr Max-µg/m3 24-hr Ave-µg/m3
Maximum 454.00 192.35 
Mean 69.95 30.84 
1995 
Std. Deviation 57.00 20.67 
Maximum 461.00 145.53 
Mean 70.00 29.97 
1996 
Std. Deviation 54.87 18.86 
Maximum 376.00 158.38 
Mean 62.92 27.18 
1997 
Std. Deviation 50.04 17.95 
       Maximum  400.00 147.10 
Mean 60.10 27.32 
1998 
Std. Deviation 47.29 17.40 
      Maximum 379.00 141.59 
               Mean 66.16 27.21 
1999 
Std. Deviation 53.35 18.59 
       Maximum  490.00 150.00 
Mean 56.57 25.57 
2000    
Std. Deviation 47.30 16.71 
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Figure 2: Mean and maximum PM10 µg/m3 levels for Allegheny County, 1995-2000 
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A search of the USEPA Toxics Release Inventory (TRI) database identified industrial 
sites in this part of Allegheny County that reported high amounts total air emission of toxic 
chemicals through stack and fugitives in 2001 (Table 8).  According to the USEPA, the TRI data 
reports toxic emissions and other waste management activities of chemicals with no inference to 
human health.  However, the data serves as a good starting point in research of exposure and 
health outcomes. Allegheny County houses several chemical plants, including several coke 
plants, as well as other heavy manufacturing facilities.  Most of these plants are strategically 
located along the main river valleys, which have topography of jagged hills, and valleys that can 
entrap pollution during a temperature inversion.  An example of these sites is the Neville Island 
located on the Ohio River, whose toxic release inventory, account for 25% of the annual toxic 
chemical releases in Allegheny County. The USEPA declared portions of the Neville Island as a 
Superfund Waste Site in April 1990.  Another plant, in the southwest of Allegheny County 
reported 1,175,414 lbs total air emissions in 2001, reporting the largest emission amounts that 
year. Allegheny County housed 6% of the TRI sites in the state of Pennsylvanian and contributed 
7% to the total reported emissions in the state for year 2001. The aim of the SHAPE study was to 
consider all these factors of environmental concerns and to determine if susceptible populations 
are affected deleteriously during short-tem exposures to variable air pollution concentrations. 
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Table 8: Selected Allegheny County TRI sites showing quantity of emissions by facility: 
2001 
 
 
Name of Facility Fugitive Air 
Emissions 
Stack Air 
Emissions 
Total Air 
Emissions 
On /Off Site 
Emissions 
 
Guardian Industries Corp Floreffe  0 84,919 84,919 84,945 
Large Plant of TYK America INC. 500 1,000 1,500 1,500 
Liberty Pultrusions 0 750 750 750 
Safety-Kleen Systems (414502) 0 5 5 5 
Tech MET INC 491 967 1,458 1,458 
Whemco-Steel Castings INC 43 0 43 7,953 
USS Clairton Works 879,785 295,729 1,175,510 1,616,860 
USS Mon Valley Works Irvin Plant 9 21,982 21,982 65,937 
*TOTAL ALL ALLEGHENY 1,238,280 5,396,079 6,634,360 15,639,800 
 
 
Sites are shown of Zip Codes area 15025, 15122, 15045, and 15120. *Total All Allegheny is emission totals in 
pounds (lbs) of all of the 94 self-reported sites in Allegheny County, 2001  
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3.2 Study Design  
This is a longitudinal study that involved participation of individuals over a period of 60 days to 
assess whether there is an association between ambient air pollution exposure and 
cardiopulmonary illness.  Participants monitored their peak expiratory flow rates, acute 
symptoms and medication use for a maximum of two months.  The relationship between PM10 
and cardiopulmonary responses of daily peak expiratory flow rate (PEFR), as well as anti-
inflammatory medication use can be expressed in a hypothetical way where exposure can result 
in either respiratory or cardiovascular conditions or both (Figure 4).   There is no direct 
relationship between exposure and medication. However, exposures to air pollution triggers the 
respiratory or cardiac physiological mechanisms resulting the need for an individual to regulate 
their medication use (Figure 4). Because of lack of individual exposure and utilizing ecological 
exposure, the assumption of this type of study is that all participants are exposed to the same 
levels of particulate matter in a given period.  The effect on all participants will be relatively 
similar regardless of health condition.   
All measurements were obtained from a population living within the same area and at 
varying periods of the year with each individual participating for a consecutive 60-day maximum 
period.   The data acquired from the study participants were repeated measurements, which make 
it possible to establish, with some detail, the temporality of causal associations and to examine 
acute exposure-response relationships at the level of an individual subject.  When a study is of 
repeated measure, subjects can act as their own control over time, analogous to a clinical 
crossover trial (Delfino et al., 2002; Checkoway et al., 2000; Mittleman et al., 1995).  
Longitudinal design with repeated measures can be an efficient way to maximize information 
derived from a small number of subjects (Stokes et al., 2001; Rochon J, 1998).  According to 
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Delfino, (2002) power and precision in longitudinal studies can be enhanced because the 
repeated measures reduce the variability of the response variable without reducing the magnitude 
of the true exposure-response relationships.  Thus data from each subject is expected to be 
correlated overtime. 
 
 
 
Figure 3: A hypothetical schematic of patho-physiological response to PM10 exposure 
 
 
 
 
 
 
 
 
 
 
 
 
Daily Symptoms ↑↑ 
Daily Medication ↑↑ 
Daily Peak Flow ↓↓  
PM10
Figure 4: A hypothetical relationship of daily medication and PM10 exposure 
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 3.3 Study Population 
3.3.1 Sample size 
  
Sample size is estimated with a desire to detect the smallest difference if one exists.  Hoek et al. 
(1998) reported on a panel study and outcomes of respiratory symptoms increases of 1-3% 
associated with a 10 µg/m³ increase in PM10, and 0.1% decrease of the peak expiratory flow rate 
(PEFR) at the same exposure and significant relative increase of 2.7% (95% CI 1.6-3.8) in 
prevalence of decrements greater than 10%. Koenig et al. (1993) reported similar results with a 
single case group 30 out of the 326 participants. Osunsnya et al., (2001) showed a 19% increase 
in PEFR decrements of 10% in a study population of 44, with 27 having complete data for PEFR 
analysis.  Other studies have reported on borderline PEFR decrements (Penttinen, et al., 2001) 
with 57 participants.   
Many air pollution studies have used peak flow meters to measure pulmonary function 
(Timonen and Pekkanen, 1997; Pettinen et al., 2001; Penttinen et al., 2002; Yu et al. 2000; 
Osunsanya et al., 2001).  A peak flow meter is a small portable inexpensive device with a 
measuring gauge that ranges from 60 to 800 L/Min. A peak flow meter measures the force and 
speed that the air is blown out of the lungs giving a PEFR.  The unit of the PEFR is L/Min.  
Daily PEFR is a valuable tool to detect early warning signs of airways responses that may 
indicate removal from a triggering exposure, adjustment of medication or adding new 
medication. The normal PEFR depend on age, sex and other factors but should be within 80% to 
120% of personal best. The OMRON Peak Air flow meter (Model PF9940) was selected because 
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of its easy instructions, durability, portability and re-usable mouthpiece, good grip handle for the 
elderly and inexpensive cost.  
In this study we were expecting a small change in PEFR. Our sample size is based on a 
e mple size determination is calculated at alpha arbitrarily set at .05, power 
repeated measures longitudinal study sample size calculation although it is assumed single 
and the upper level of the confidence interval with an alpha =. 05 (two tailed), beta 0.20 (power 
tical analysis of repeated measures using the generalized 
estimation equation (GEE) procedures are efficient even for s
subjects; Osunsanya et al., 2001, twenty seven of the 44 subjects had complete data; Penttinen et 
therefore decided on a sample size of 30 subjects because this would give us the power that we 
 
 
small ffect size.  Sa
.80 and a small effect size of .22.  According to Stevens, (1986), there are no real tables for 
sample case correlation for repeated measures can be used.  Using the tables provided by 
Stevens, (1986) and assuming power of .80 and a small effect size of .22 at alpha =.05 and 7 
repeated measures we would require a sample size of 47.  The sample size requirement gets 
smaller with the number of repeated measures and selected effect size.  Using this information 
80%) the sample size needed would be about 30 subjects.   
Additionally, the statis
mall sample sizes (Rochon, 1998).  
Similar studies have recruited similar sample sizes (Delfino et al., 2002& 2003, twenty-two 
al., 2001, fifty seven subjects; de Hartog et al., 2003, ranged from 37 to 47 for each city).  We 
wanted to achieve and also constraints of financial and personnel for a quality control is 
achievable with this sample size. 
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3.3.2 Population 
The SHAPE study was conducted in the southwestern part of Allegheny County. Participants 
who we
acute respiratory illness (ICD-9 code 
460-46
e group most likely to comply and perform daily PEFR, and 
complete the medication and the symptom components of the diary (Geyh et al., 2002).   
nly subjects with a confirmed pulmonary disease or heart disease were admitted to the 
study.  The medical group practice physicians identified and invited into the study subjects who 
re regular patients of the Pulmonary and the Cardiac Outpatients Clinics were identified 
by the physicians from their database and invited to participate on the study.  The University of 
Pittsburgh Institutional Review Board (IRB) approved the study protocol IRB #301014.  
Subjects who signed an informed written consent were allowed to participate on the study. 
Subjects received a monetary incentive for their participation on the study.    
To be eligible for the study, the subject had to meet the following criteria:  (a) A positive 
physician-diagnosed respiratory or circulatory disease identified by the International 
Classification of Disease, 9th edition, World Health Organization, Geneva (ICD-9) codes that 
include asthma (ICD-9 code 493), COPD (ICD-9 code 490-496, excluding 493), pneumonia 
(ICD-9 code 480-487), acute bronchitis (ICD-9 code 466), 
6), and a circulatory disease such as CHF (ICD-9 code 428) <40% ejection fraction, Class 
II-III angina symptoms, myocardial infarction (ICD-9 code 410), conduction disorders (ICD-9 
code 426), and dysrhythmias (ICD-9 code 427),  (Zanobetti et al., 2000); (b) Age from 50 to 79 
years; (c) A resident of a selected area of south west Allegheny County; (d) independent living. 
A total of forty-nine (49) subjects agreed to participate on the study. The cohort 
represented subjects who were able to complete the study based on their willingness indicated by 
their return of a post card of invitation to the study.  Additionally, the age and health restrictions 
implied that this would be the ag
O
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were adults aged 50-79 years old with a respiratory or circulatory disease identified by the 
re younger than 50 
years.  
r 
respons
otential 
subject
International Classification of Disease, World Health Organization, Geneva (ICD-9) codes 
classification (Table 3.7). 
 
3.3.3  Exclusion Criteria 
Individuals were excluded from the study if they did not have respiratory and circulatory disease 
diagnosis criteria as defined in the inclusion criteria and individuals who we
Individuals with severe forms of cardiopulmonary diseases such as lung cancer, or Class 
1 or IV angina symptoms were also excluded from the study. Individuals who did not give a 
written consent were automatically excluded from participation. 
 
3.3.4 Recruitment Procedures 
The physicians mailed letters to potential subjects informing them of the study and inviting them 
to participate.  The physician did not make available or pass on medical information of a 
potential subject to the investigators.  The potential subjects received an envelope that included a 
postcard which they mailed back in a stamped addressed envelop to the physician with thei
e.  If a potential subject indicated on the postcard that they want to be contacted by an 
investigator with further information about the study, an investigator contacted the potential 
subject by phone and made arrangements for a clinic visit that took place at their home or 
doctor's office. The visits lasted approximately 45 minutes. 
At the initial visit the investigator informed the subject of the study and gave the p
 a consent form to review and complete if interested in being enrolled in the study. If the 
subject met the study eligibility criteria, he/she was asked to complete a questionnaire on 
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environmental exposures. The investigator instructed the subject on the correct method of 
performing a peak flow test and demonstrated how to record the results in the daily symptoms 
diary. The subjects were contacted weekly by phone to reinforce the proper use of the peak flow 
meter and to ensure that the diary entries are completed appropriately.  
 and modified from a previous 
asthma Zareba, et al., (1999); an indoor air pollution 
i et al., (1995); and air pollution and respiratory symptoms by 
The stu
 
3.3.5 Environmental Health Study Questionnaire  
Participants were asked to complete an environmental health study questionnaire (EHSQ) 
(Appendix A.1) at the beginning of the study to ascertain the subjects’ pre-existing health 
conditions, smoking history, assess socio-demographic status and indoor environmental 
exposures. Some of the questions used in EHSQ were adapted
 and risk of cardiac events study by Rosero, 
and asthma events study by Simoy
de Hartog, et al., (2003).  The EHSQ addressed the demographic information, respiratory and 
cardiac symptoms, housing conditions, and possible sources of indoor air pollution such as 
household smoking, heating sources used, and home dampness. The data from the EHSQ 
questions were analyzed to describe the conditions of indoor air pollution, the perceptions of the 
study participants to air pollution in their community and to assess their previous 
cardiopulmonary health status. 
 
3.3.6 Peak Expiratory Flow Rate (PEFR) Procedure   
dy subjects were instructed to measure their PEFR every day in a sitting position 
immediately after getting up in the morning (6:00 am-8:00 am), and in the afternoon (2:00pm-
6:00pm) before taking any medication. The PEFR maneuver was demonstrated. The test requires 
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that the subject take three readings at each time and records the best (highest reading) of the 
three PEFR maneuvers in the morning and in the afternoon. At the end of the study PEFR data 
was entered into the data base using the methods described by Osunsanya et al., (2001) and by 
Hoek et al., (1998) that provides a sound clinical comparison between peak flow and prevalence 
of acut wer respiratory symptoms.   First, the actual values were entered in the database.  
percentage decrement by subtracting the 
e lo
Secondly, we calculated the individual’s daily PEFR 
daily PEFR from the mean PEFR divided by mean PEFR.  Thirdly, we calculated from the initial 
PEFR variable and the percentage decrement a binary variable that represented the presence or 
absence of a 10% decrement. 
  
3.3.7 Daily Medication Use  
Subjects were asked to record daily their medication and patterns of medication use.  Subjects 
recorded medication as to whether there is no change in medication dose (record =0), whether 
medication dose is increased (record= 1) and whether medication decreased (record 2).  At the 
end of the study records of medication were categorized into anti-inflammatory and non- anti-
inflammatory using a binary “Yes” or “No” (Delfino et al., 2002 &2003) for analysis.   
 
3.3.8 Daily Cardio-Pulmonary Symptoms  
Participants reported the daily severity of symptoms using a scale that incorporates the impact of 
n daily activities.  Subjects rated the the severity of respiratory and cardiovascular symptoms o
symptoms in terms of a 4-level ordinal scale. On each day the subjects ranked the symptoms 
with “0” if no symptoms are present, a “1” if mild symptoms are present but do not cause any 
discomfort, a “2”, if moderate symptoms are present and cause discomfort but do not interfere 
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with daily activities or sleep and a “3” if severe symptoms are present and interfere with most 
activities and may cause the subject to stay in bed, return from work, call or visit a doctor or 
hospital.  At the end of the study all symptoms were dichotomized for data entry in the database 
as binary variables of 0 and 1 (reported scale 0 represent no symptoms and scale 1-3 of mild, 
moderate, severe represents symptoms =1), (Delfino et al., 2002 & 2003, Yu et al., 2000, 
Pentitinen et al., 2001).  If a subject reported any one of the symptoms, the subject was defined 
as having presence of symptoms.  
Subjects also entered a “Yes” or a “No” to a question “did you have any of these 
symptoms today?”  Questions on muscle aches, nose congestion, runny nose, fever or achy 
chills, and headache required the subject to answer a “Yes or a “No.”  These symptoms were 
or no respiratory infection symptoms and =1 for respiratory 
he participants were followed-up weekly by phone to assess the compliance of PEFR 
 B.1) maintenance and to identify any adverse 
entered in the database as =0 f
infection symptoms if more than one of the symptoms are reported (Delfino et al., 2002).  
A record of emergency room or unscheduled doctor’s visits, exposure to tobacco, and 
time spent outdoors or away from home were also recorded daily in the diary.  
 
3.3.9 Quality Control and Management of Data 
T
monitoring and symptoms diary (APPENDIX
events during peak flow tests.  In addition the participants were given a 5 ½" by 8 ½" card with 
instructions on each component of the study that included Instructions for Recording Peak Flow, 
Instructions for Recording Your Medication, Instructions for Recording Symptoms, Instructions 
for Recording other Symptoms and Questions. The card included instruction on what to expect 
from the investigators each week, at the end of 1 month and at the end of the 2nd month. Contact 
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information was given at the end of the card for participants to contact the investigators with 
concerns.  Participants were advised to keep the card on a refrigerator with a magnet or on a 
bedside table.   
At the end of the first month (4 weeks), a clinic visit was arranged to collect the diaries 
and to give the subject another diary to continue the study during the second study period.   This 
visit enabled the study staff to assess the data for compliance and errors.  
 
3.3.10 
gh the 
Clean A
cal monitors that 
measure ambient criteria pollutant levels. The two types of samplers used for PM10 are a high 
e illating microbalance (TEOM). The TEOM 
Data Sources for Ambient PM10 
A database of air pollution PM10 levels monitored by the Allegheny County Health Department 
(ACHD) Air Quality Division was obtained for the eight continuous stationary monitors. The 
ACHD Air Quality Division measures criteria air pollutant PM10 using the USEPA reference 
methods.  Air monitoring for ambient levels of criteria pollutants was promulgated throu
ir Act of 1970. The ACHD is the primary regulatory body for monitoring air emissions 
and ambient air quality for the county.  There are various types of mechani
volum  (hi-vol) air sampler and a tapered element osc
air sampler is a USEPA equivalent monitor used for air quality index calculations. These 
monitoring samplers are operated continuously and the results reported electronically.  
There are 21 air pollution-monitoring sites that have multiple ambient air samplers 
throughout the Allegheny County. These locations do not necessarily reflect a true ambient level 
concentration representative of the county. Since the start of the ACHD regulatory program, 
some of these facilities have either stopped operations or relocated. Of the 21 sampling locations, 
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8 sites had continuous monitors for PM10 levels using the TEOM methods with data logger, and 
telemetered to central computer by each hour.  
Some of the ACHD monitoring sites, such as the Liberty Borough monitoring site, were 
initiate
ino et al., 2002 &2003; 
esqueyroux et al., 2002). Data on the hourly and 24-hourly PM10 concentration, 24-hourly 
r the period of May 1, 2003 to May 31, 2004 from all 
te, yet no 
signific
d for compliance of air polluting sources from the major coke plant in the area.  Such 
measurements provide the area background exposures similar to other studies (Penttinen et al., 
2001; de Hartog et al., 2003; Osunsanya et al., 2001; Yu et al., 200; Delf
D
maximum and minimum were obtained fo
of the 8 ACHD continuous monitoring sites. 
  A few studies on environmental epidemiology studies have correlated the standard 
USEPA monitoring data to the indoor and outdoor air of individual homes to ascertain whether 
indoor air correlates to ambient exposures (Leaderer et al., 1999).  Leaderer et al., (1999) carried 
out an extensive air pollution study to assess the daily particulate exposures of inside and  
outside of 280 homes and central monitoring sites in Virginia and Connecticut during the period 
1994- 1998. The authors reported that the PM10 concentration measured at the regional sites were 
not significantly different from those measured either outside or inside of homes, neither were 
PM10 concentrations measured outside homes different from those measured inside homes. The 
study sampled homes that were located as far as 175 km from the regional sampling si
ant differences in mean concentrations of PM10 were reported.  This is one of the most 
extensive studies to characterize apportionment of central sites measurement to residents in an 
area.  Based on this assessment, our study used the data from the ACHD monitoring sites as an 
ecological independent variable and individual clinical assessments data as dependent variables.   
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Because the clinical data in this study was obtained at four different times during the 
entire study period, it was necessary to define four homogenous subgroups of participants. The 
periods
ponse relationship between symptoms and the air 
pollutio
the Pittsburgh International Airport weather station for the period May 1, 2003 to May 31, 2004.   
 were defined as June 2003, October 2003, November 2003, and April 2004.  An average 
24-hr PM10 was calculated for the entire study period to observe trend during the study period in 
general.  This average 24-hr PM10 was matched to each day for that period to enable us to 
calculate the daily PM10 deviations which was calculated by subtracting the average PM10 of each 
day from the average 24-hr PM10 of that period.  Scatter plots were analyzed to assess this 
deviation from the mean.  We also calculated a 10 µg/m3 increment variable from the average 
24-hr PM10 to enable us to assess a dose-res
n. Additionally, we calculated a daily change in average 24-hr PM10 and a daily change 
in PEFR by subtracting the previous day level from the present day in order to assess a 
relationship between the two variables.   
 
3.3.11 Meteorological Data   
 
Weather variables can confound the effect of air pollution on health outcomes. The weather 
variables of interest were temperature, dew point average, pressure and relative humidity because 
of their interrelationship and their effect on health outcomes. Studies have shown that these 
weather variables can affect individuals in different ways including ischemic heart disease, 
higher blood pressure changes and death (Donaldson and Keating, 1997; Eldwood et al., 1993. 
The daily averages of temperature, dew point average, pressure and relative humidity were 
obtained from the National Weather Service, the National Oceanic and Ambient Air agency for 
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  the physicians at the out-patients clinics identified 
participants to invite to the study. Zip codes boundaries do not always match the street or county 
 were recruiting participants in the intended area we used the 
eographic information system (GIS) in two stages. First, we geocoded the participants’ address, 
 
 
3.3.12 Recruitment Area Boundaries Using GIS Mapping 
Subjects were recruited from an area within 15km from the identified TRI sites associated with 
zip codes of interest.  Different studies have used arbitrarily assigned boundaries for similar 
recruitments.  Penttinen et al., (2001) restricted their entire study group to within 2 km of the air 
quality-monitoring site; Leaderer et al., (1999) up to 175 km; Vichit-Vadakan et al., (2001) 2km; 
Haree et al., (1997) 5 km; Delfino et al., (2003) 3 mile radius. Participants who resided in the 
selected 0-15 km zones drawn around identified eight toxic release inventory sites were eligible 
to participate on the SHAPE study.  
Using the zip codes resolution,
boundaries. To ensure that we
g
that is, we transformed addresses into X and Y coordinates using MapInfo /ArcGIS (Bellander et 
al., 2001).  The street addresses were matched to the nationwide US Census Bureau database of 
streets and enabled us to geocode all the participants’ addresses resulting in this map (Figure 5). 
Secondly, we generated buffer zones around the identified 8 TRI plants for a distance of up to 
15km. The process involved representing each TRI sites on the map as a point and resulted in the 
map below (Figure 6).  Notice that a number of participants fall within 5km of the TRI plants 
with only one participant in the west lying beyond the 15km buffer zone. 
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We also considered the contribution of traffic emissions to air pollution in Allegheny 
ounty.  We generated a map of the road networks in the area to visualize the possible influence 
f traffic emissions health.  The map showed that the area of study has lesser road density in the 
 direction in the Allegheny region 
C
o
south and begins to congest northwards (Figure 7).  The wind
is frequently NE direction. If the frequently observed wind direction is taken into consideration, 
the NW effect is probably not pronounced. This assessment was not pursed further in this study 
but was performed as a precursor to future air pollution study in the region. 
 
 
 
 
 
Figure 5: Address geocoding of TRI facilities in relationship to participants’ residents 
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Figure 6: 5-15km buffer zones around TRI facilities and addresses of participants 
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 Figure 7: Geocoding of TRI sites and study participants showing road networks dispersion 
 
 
 
 
 
3.3.13 Statistical Analysis of Data 
The statistical analysis of this longitudinal data was carried out systematically addressing 
each ere 
sed to explore and describe the relationships between the environmental exposures and the 
health outcomes and also to answer each hypothesis. The data was analyzed using statistical 
packages including SAS, JMP and SPSS statistical packages.  
The data was summarized descriptively for the subjects’ socio-demographics, and daily 
PEFR, symptoms and medication.  The air pollution data was examined for temporal trends for 
the average 24-hr and maximum 24-hr PM10 concentrations. The meteorological variables were 
summarized descriptively as well. The association between air pollution and health outcomes 
was analyzed using chi-square (χ2) analysis with dependent binary variables that have two levels 
hypothesis.  Univariate analysis, bivariate correlations and logistic regressions models w
u
 65
(yes/no) and coded into either 0 or 1. The tests were used to assess the probability of having 
symptoms or no symptoms in the presence of different levels of PM10 exposures.  Because of the 
small numbers and inherent longitudinal studies missing values we also performed the 
generalized estimation equation model (GEE) proposed by Kung-Yee and Zeger, (1986) and 
discussed further by Desqueyroux et al., 2002; Yu et al., 2000; Osunsanya et al., 2001; Delfino et 
al., 1998, 2002 & 2003].  The GEE model is a practical method of analysis with ability to handle 
repeated measures of a longitudinal study where data may be missing.  The GEE is an extension 
of the generalized linear model (GLM), with facilities in SAS/ GENMOD function (Stokes et al., 
2001).  According to Stokes et al., (2001), the GLM relates to mean response to a vector of 
explanatory variables as follows:  
g [E (yi)] =g (ui) = Xi’β 
where yi is the response variable (i=1,…., n), ui= E (yi), g is the link function, xi is a 
β is the vector of regression parameters to be estimated.   
ogeneous subgroups 
from the entire study participants to rem
vector of independent variables, and 
For an individual’s data to be included in the analysis a total of 30 days of participation 
(50% of an expected individual participation) was required. The reason for this was that 
participants were given a 1-month diary to complete and return before starting on another diary 
for the other month. Because the participants entered the study at varying times, first we 
analyzed data of all eligible study participants. We then created four hom
ove an imbalance that may be created by participants 
who contributed more person days than others and by individuals entering the study at varying 
times an also to assess the effect of seasonality. The subgroups also identify which period of the 
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year participants reported more symptoms because each individual fell into a distinct subgroup 
with no overlap.   
We estimated the air pollutants effect on the binary outcomes of the symptoms and the 
presence of 10% decrements of PEFR from the mean among the four groups. In addition, we 
stratified the air pollution data into six levels of PM10 concentrations in order to investigate dose-
response effects on symptoms.  Additionally, two medication groups (anti-inflammatory and 
non-anti-inflammatory) were created and examined separately to assess differences of symptoms 
outcomes in the two groups.  
 Odds ratio and confidence interval of the within subjects short-term effect of PM10 on 
health outcomes are reported. The other summary that was included was of data obtained from 
the EHSQ and included questions such as how long a subject had lived in Allegheny County; 
subjects’ perceptions of the air quality; how long a subject has lived at their current residence; 
and oth
re 
were co
er pre-existing health conditions and indoor environments.  
Meteorological variables that included mean temperature, relative humidity, and pressu
nsidered as confounding variables in order to determine the unique role played by the 
PM10 concentrations in predicting the PEFR decrements and symptoms.   
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Thirty-five individuals signed consent forms, completed the 
environ
ted less than 40 days each to 
the stud
sis. 
ar diseases and twenty-
two (69%) of the participants reported a respiratory disease diagnosis. Twenty two percent of the 
participants had a history of asthma and 31% reported a history of other lung diseases.  The 
participants reported their previous diagnosis that included heart diseases (22%), chronic 
obstructive airways disease (13%), and myocardial infarction (2%).  Seventy percent of the 
participants had their current diagnosis before age 65.   
 
4.0 RESULTS 
 
4.1 Response Rate 
Forty-nine individuals agreed to participate on the study by mailing back a post card to the two 
medical center physicians. 
mental health study questionnaire and maintained symptoms diaries for a mean average 
of 54 days beginning May 21, 2003 to May 31, 2004.  Three individuals were omitted from the 
initial analysis because the number of days of participation was less than 30 days of the required 
possible days.  Of the 32 remaining eligible sample 34.4% of the individuals contributed more 
than 60 days each to the study. Four individuals (12.50%) contribu
y (Table 9).  
Table 10 summarizes the characteristics of the subjects included in the initial analy
Ten (31%) of the participants reported a current diagnosis of cardiovascul
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Table 9: Frequency of individuals’ ici mber of days contributed to study 
Number of Participatio
Days  
Percent 
part pation by nu
 
 
n Frequency 
≤ 39 4 12.500 
40 - 44 2 6.250 
45 - 49 4 12.500 
50 - 54 2 6.250 
55 - 59 5 15.625 
≥ 60 15 46.875 
1716 32 100.00 
 
 
 
Thirty four percent of the participants reported that they had been hospitalized in the past 
year for their current cardiopulmonary condition. Forty one percent reported a past history of 
emergency room visit and 19 % reported ever being placed on a ventilator in the past. Eighty one 
percent of the participants reported that exposure to environmental factors such as cold air; 
humidity, exercise, dust and dander triggered their respiratory or heart problems or bring on an 
attack of cardiopulmonary condition.  All the participants reported that they had lived in 
Allegheny County for more than 36 years. When asked about their perception of air pollution in 
Allegheny County, 84% of the participants believed that the air pollution has improved.  Nine 
percent of the participants reported a past history of smoking and exposure to secondary tobacco 
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smoke and 3% reported being current cigarettes smokers.  Thirty five percent of the participants 
reported that they live in houses that are less than 50 years old and 31% reported having damp 
rooms or basements in their homes.  When asked about the type of heating source in the home, 
8  
sults showed that the participants spend 29% of the time more than 10 miles away from home 
during the study period. The results also showed that on average the participants spend 69% of 
their time indoors.  
4.2 te Measurements 
The analysis of each of the eight onitors in Allegheny County showed that Lincoln had 
the highest average PM10 levels (35 µg/m³) followed by Braddock (31 µg d Liberty (31 
µg/m³) (Table 11) during the study period May 1, 2003 to May 31, 2004.  The average 24-hr 
PM10 across the monitoring sites was 24.36 µg /m3 with a standard deviation of ±13.65 µg/m³, 
and the maximum PM10 was 447 µg/m3 (Table 12).  The percentiles of the average PM10 were 
13.63 µg/m3 (25%), 20.93 µg/m3 (50%) and 31.61 µg/m3 (75%).  
2% reported that they use gas-heated forced air and 9% use steam and water radiators.  The
re
Particula
fixed m
/m³) an
The data was also examined by month for the average 24-hr PM10 (Figure 8) and showed 
that the highest average levels were recorded in June 2003 and the lowest levels in January 2004.  
A linear regression was performed to model the relationship between PM10 and time of study in a 
model form: 
 Y = a + bX, where X is the explanatory variable and Y is the dependent variable, with 
slope of the line b, and a, the intercept.  A linear regression line did not show a notable trend to 
indicate an association between the average 24-hr PM10 (p= 0. 7336) variables with date of 
observation.  
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The PM10 deviations from the average 24-hr PM10 were calculated by month and showed 
a clustering between -20 µg/m³ to 56 µg/m³ (Figure 9).  The deviation from the mean was 
greatest during the month of June followed by December and October 2003. However, a linear 
regression line did not show a notable trend (p=0.8465) to indicate an association between the 
PM10 deviations from the average 24-hr PM10 and date of observations. In general, the PM10 
correlation analysis of the data from the 8 monitoring sites showed that all the monitors were 
significantly correlated (p< 0.01) for the average 24-hr PM10 (Table 13). A strong positive 
correlation ranging from 0.629 to 0.905 was observed between all the monitors except for the 
Liberty site where the correlation ranged from 0.382 to 0.487. 
4.3 Meteorological Measurements 
F) followed by July and June 
2003. T
 
The average mean temperature (MNTP) was 59° F, with the highest temperature recorded at 
79°F.  The data for the MNTP was examined by month and year and the results showed that the 
month of August 2003 had the highest recorded temperature (79°
he months of January and February 2004 and December 2003 recorded the lowest 
temperatures. The mean relative humidity (MNRH) was 53.57 %, dew point average temperature 
(DPTP) 43.15 °F, and pressure (PRES) 28.75 inHg (Table 14).   
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 Frequency Percent 
 
 
 Table 10: Summary characteristic of study population (N=32) 
 
Race                
Black 1 3 
White 31 97 
Gender     
Male 16 50 
Female  16  50 
Have you ever been told by a physician that you have a lung or   
heart disease? 
Lung disease 10 31 
Asthma 7 22 
Heart disease 7 22 
Chronic obstructive pulmonary disease 4 13 
Myocardial infarction 2 6 
Congestive heart failure 3 1 
Emphysema  3 1 
Have you ever been admitted to the emergency room for   
heart/lung problems? 
No 17 53 
Yes 13 41 
Unknown 2 6 
Have you ever been admitted to a hospital for respiratory or   
heart problems in the past year? 
No 21 66 
Yes 11 34 
Have you ever been placed on a ventilator?   
No 26 81 
Yes 6 19 
Are you still being treated for lungs or heart problems?   
Respiratory 22 69 
Cardiovascular 10 31 
What factors aggravate your respiratory or heart problems or 
bring on an attack? 
  
Some triggers (cold, humidity, exercise, dust, other) 26 81 
None 5 16 
Don’t know 1 3 
What is the main source of heating in your home?      
Gas- heated forced air (vents) 26 82 
Radiators (steam or water) 3 9 
Electric- heated forced air (vents) 2 6 
Gas stove/fireplace/wall furnace 1 3 
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Table 10 (Cont’d) 
Frequency Percent 
A s including basement in your house that are 
d
  re there room
amp? 
No 20 63 
Yes 10 1 3
Missing 2 6 
H
C
as the air pollution improved since you first lived in Allegheny 
ounty?   
  
Improved 27 84 
No change 4 13 
Don’t know 1 3 
 
Table 11: Descriptive statistics of average 24-hr and maximum PM10 by monitoring site: 
Allegheny County May 2003-May 2004 
 
 
N Maximum Mean Std. D
 
 
 ev 
Avalon 391 77 19.85 11.23 
Braddock 397 104 31.40 20.28 
Flag Plaza 397 77 21.62 11.17 
Glassport 397 114 23.61 17.35 
Hazelwood 397 54 18.30 9.85 
Liberty 397 126 27.05 21.20 
Lincoln 397 189 35.23 28.14 
Stowe 397 69 17.81 13.65 
     N= total number of days of o
3
bservations during the study period. The ximum an an  
. 
 ma d me
     PM10 is expressed in µg/m
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Table 12:  Summary statistics of PM10 for Allegheny County: May 2003-May 2004 
 
 
-hr Ma imum 24-hr 
 
 
  Minimum 24-hr Mean 24 x
N  397 397 397 
Mean  2.71 24.36 132.93 
Std. Dev  4.15 13.65 90.82 
Minimum  0.00 4.28 10.00 
Maximum  27.00 79.46 447.00 
Percentiles 25 0.00 13.63 63.50 
 50 1.00 20.93 100.00 
 75 4.00 00 31.61 191.
 100 2  00 7.00 79.46 447.
                mber o s of observatio The mean Std. D n and percentiles of PM10 is  
                   ed in µg/m
 
 
 
 
 
 
 
 
 
 
 
 
   N= total nu f day
3
ns. eviatio
 express
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Table 13: Correlation coefficients of PM10 for the Allegheny County monitoring sites: May 
2003-May 2004 
A
va
lo
n 
B
ra
dd
oc
k 
G
la
rt 
Li
be
rty
 
Li
n 
St
ow
e 
 
 
 
Fl
ag
 P
la
za
 
ss
po
H
az
el
w
oo
d 
nc
ol
Avalon 1 .817* .905* .800* .853* .424* .721* .838* 
Braddoc  1 .785 02* .7 11* 23* k * .8 53* .4 .719* .7
Flag   .835* .473* .867* Plaza 1 .878* .704* 
Glas    1 . .487* .755* sport 781* .837* 
Hazelwood    .382* .848*  1 .641* 
Libe      1 .401* rty .456* 
Lincoln       1 .629* 
Stowe        1 
N=391 for Avalon, 397 for all other sites. * Correlation is significant at p < 0.01 
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Table 14: Summary statistics of meteorological variables: Allegheny County May 2003-
May 2004 
 
 
  DPTP °F MNRH % MNTP °F PRES inHg 
 
N  397 39 97 7 397 3
Mean  43.15 53.  .75 57 52.16 28
Std. Dev. .67 15.  171  17 38 17.42 0.
Minimum  -2.60 17.00 9.00 28.24 
Maximum  69.30 100.00 79.00 29.29 
Percentiles 2 8.70 42.00 3 0 .645 2  9.0 28  
 50 46.40 52.00 56.00 28.76 
 75 57.95 64.00 67.00 28.87 
 10 .30 100.00 7 0 29.30 0 69  9.0
 
DPTP= a um relative 
humidity in barometric expressed in whole percent. MNTP= average temperature in degrees Fahrenheit. 
PRES=average daily station pressure expressed in inches of mercury (inHg). N= total number of days of 
observations during the study period 
 
 
 
 
 
verage daily dew point temperature in tenths of degree Fahrenheit. MNRH= minim
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Figure 9: Average deviations from the Mean PM10 by month and year 
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4.4 Association between PM10 and Meteorological Conditions 
A bivariate correlation of PM10 and meteorological variables showed a positive correlation 
between average 24-hr PM10 and mean relative humidity (MNRH) and dew point (DPTP). There 
was a strong positive linear association between the MNTP and DPTP (r=0.964) and a borderline 
strong linear association between PM10 and mean temperature (MNTP) and DPTP (r=0.502 and 
0.413 respectively). There was a negative linear association between DPTP and pressure (PRES) 
and between MNRH and PRES (Table 15). 
 
 
 
  
Table 15: Corre egheny County 
 
 Mean PM10 DPTP MNRH MNTP PRES 
 
lation coefficients of PM10 and meteorological variables: All
May 2003-May 2004 
 
Mean PM10 1 .413* .502* -.067* .173* 
DPTP  1 .209* .964* -.239* 
MNRH   1 -.022 -.374* 
MNTP    1 -.139* 
PRES     1 
 
DPTP= average daily dew point temperature in tenths of degree Fahrenheit. MNRH= minimum relative humidity in 
barometric expressed in whole percent. MNTP= average temperature in degrees Fahrenheit. PRES=average daily 
station pressure expressed in inches of mercury (inHg). N= total number of days of observations during the study 
period. The mean PM10 is expressed in µg/m3. *Correlation is significant at p < 0.01 
 
 
 
4.5 Physiological Responses 
o assess if there is an association between air pollution and the health outcomes among the 
individuals, four homogeneous groups were created for the study period. Two participants were 
T
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omitted from na ey could not 
be fitted into any of the groups because of the overlap of their minimum days of participation 
over two periods of study.  The final group of participants resulted in 895 person days (Table 
16). 
 The data from the diaries were analyzed to assess participants’ experience of symptoms 
during the study period. A subject was defined as having presence of symptoms if they reported 
any one of the symptoms such as shortness of breath, chest pain, fatigue, cough, wheezing 
related to cardiopulmonary diseases.  Participants reported symptoms 59% times during the 
bservation period.  
f persons experiencing each of the  reported high frequency of cough, 
 by shortness of breath and fatigue during the 
study  June, 2003 able 1 ure 1 uring t dy perio  October, 
Novem ipants did not report any sym
were no reports of frequent cough during the month of pril, 2004. 
Figure 11 shows the analysis of total symptoms and use of anti-inflammatory medication 
e 
% symptoms experience. 
uring the study period of October 2003 the participants were on anti-inflammatory medication 
1% and they reported experience of symptoms 71% of the time. 
 
 
 
this a lysis. The reason for omitting the two participants is because th
o
Further, data was analyzed to assess person days (PD) of symptoms reports and number 
symptoms. Participantso
chest pain, shortness of breath, being awakened
period of  (T 8, Fig 0). D he stu ds of
ber 2003 and April 2004, partic ptoms of chest pain.  There 
 A   
for each study period.  The results showed that during the study period of April 2004, all th
articipants were on anti-inflammatory medication and reported 51p
D
7
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Table 16: Study Periods showing frequency and percent of person days contributed 
  
Participants Days N=895 
 
 
Study Period Number of Frequency of Person Percent 
June 2003 8 239 26.7 
October 2003 9 266 29.7 
November 2003 8 240 26.8 
April 2004 5 150 16.8 
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Figure 10: Percent of reported daily symptoms by study period 
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Table 17: Frequency person-days and percent of reported daily symptoms  
 
 
Daily Symptoms Jun 003 Oct 003 November 2003 April 2004 
 
 
e 2 ober 2
 n PD % n PD % n PD % n PD % 
Any frequent cough 5 75 31.4 1 6 2.5 1 15 6.3 0 0 0 
Any cough first thing this 
morning? 
2 6 2.5 5 109 41.0 5 64 26.7 3 10 6.7 
Any cough during the day? 2 7 2.9 6 107 40.0 5 67 27.9 3 37 24.7 
Any phlegm first thing this 
morning? 
2 21 8.8 4 80 30.1 6 67 27.9 4 54 36.0 
Any phlegm during the day? 2 21 8.8 4 80 30.1 5 67 27.9 4 48 32.0 
Troubled by shortness of 
breath?    
2 8 3.3 5 79 29.7 5 38 15.8 3 47 31.3 
Stopped for breath while 
walking on level ground?    
2 6 2.5 4 60 22.6 3 47 19.6 3 39 26.0 
Any wheezing or whistling 
sound from your chest?    
1 4 1.7 4 27 10.2 4 44 18.3 1 5 3.3 
Any Chest Pain? 3 35 14.6 0 0 0 0 0 0 0 0 0 
Any Shortness of breath? 3 68 28.5 2 31 1.7 0 0 0 0 0 0 
Any Fatigue? 3 38 15.9 2 6 2.3 0 0 0 0 0 0 
Awakened by shortness of 3 37 15.5 1 15 5.6 0 0 0 0 0 0 
breath? 
The table represe and the percent 
person days when ay 31, 2004 
nts the total number of persons (n) reporting the symptoms, person days (PD) 
 symptoms were reported during the four study periods during May 21, 2003 to M
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 4.6 Peak Flow Rate (PEFR) Measurements 
he peak expiratory flow rate (PEFR) records of the participants ranged from a minimum of 100 
liters/minute (L/Min) to a maximum of 650 L/Min and an average of 295 L/Min.  When the data 
was examined by study period, the results showed that the mean PEFR for June 2003 were much 
higher for both the morning and the afternoon rates compared to the other study periods (365 
L/Min).  The study period of April 2004 had the lowest mean PEFR (Table 18).  The morning 
PEFR and afternoon PEFR were examined further for daily decrements from the mean and 
calculated for each study period (Tables 19).  The PEFR decrements ranged from –40 L/Min to 
45 L/Min.  The largest mean decrements were observed for months of June (-2.27 L/Min for 
morning PEFR; -3.39 L/Min for afternoon PEFR).  
4.7 Association between PEFR and PM10 
To assess a relationship between PEFR and PM10, a liner regression was examined for the 
morning PEFR deviations and the average 24-hr PM10. The morning PEFR showed more records 
of complete data compared to the afternoon PEFR and thus was used in the bivariate analysis. A 
trend analysis was carried out using the JMP stat tical package for linear fit. The results of the 
d
PEFR) by the average 24-hr PM10 changes (i.e. differences of present day's average 24-hr PM10 
minus previous day's average 24-hr PM10) yielded a non significant statistical levels between the 
two variables (p=0.6100) (Figure 12).  A bivariate analysis of the morning PEFR deviations and 
the average 24-hr PM10 results also showed a non significant trend line (p=0.0640) (Figure 13).  
T
is
ifferences of the morning PEFR (i.e. differences of present day's PEFR minus previous day 
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Both analyses showed no association between da y changes in PM10 and daily change in PERF. 
Thus the PERF appear n  b ssment.  
 
 
 
 
Study Period Time of PEFR Missing N Min Max Mean 
il
ot to e a sensitive measure of exposure effect asse
 
 
Table 18: Average morning and afternoon PEFR by study period 
 
Measurements L/Min L/Min L/Min 
June 2003 Morning PEFR 
Afternoon PEFR 
0 
25 
239 
214 
101 
102 
650 
650 
365 
365 
October 2003 Morning PEFR 2 
Afternoon PEFR 9 
264 
257 
140 
140 
450 
430 
281 
308 
November 2003 Morning PEFR 0 240 120 400 225 
Afternoon PEFR 0 240 120 490 267 
April 2004 Morning PEFR 0 150 110 350 242 
Afternoon PEFR 0 150 145 350 256 
 
PEFR= peak expiratory flow rate. N= total number of peak flow tests performed during each of the study 
periods for both the morning peak flow and the afternoon peak flow. Min=minimum average, Max= 
 
maximum average peak flow rates liters per minute (L/Min) 
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Table 19: M daily mean 
 D
M
M N M
dec
L/Min 
M
dec
L/Min 
M
dec
L/Min 
 
 
ean minimum and maximum peak flow rate decrements from the 
 
 
Study Period aily Time of 
easurements 
issing  in 
rement 
ax  
rement 
ean 
rement 
June 2003 M
A
0 
25
2
2
-
-
-2
-3
orning PEFR 
fternoon PEFR  
39 
14 
31 
35 
44 
25 
.27 
.39 
October 2003 M
Aft
2 
9 
26
25
-3
-2
27 
17 
-0
-1
orning PEFR 
ernoon PEFR 
4 
7 
9 
6 
.37 
.02 
November 2003 Morning PEFR 
A
0 
0 
240 
2
-33 
-
35 -1.05 
-0fternoon PEFR 40 40 31 .64 
April 2004 Morning PEFR 
Afternoon PEFR 
0 
0 
150 
150 
-37 
-15 
39 
45 
1.56 
0.71 
 
PEFR= peak expiratory flow rate. N= total number of peak flow tests performed during each of the study 
periods for both the morning peak flow and the afternoon peak flow. *Minimum and Maximum average 
decrements from the mean, liters per minute (L/Min) 
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Figure 13: Bivariate Fit of Morning PEFR Day-Day Deviations by Average 24-HR PM10
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4.8 Effect of PM10 Average Increment on Physiological Responses 
Table 20 shows the frequency of the 10-µg/m3 PM10 increments by the study period. The 
10 µg/m3 increments were created to assess a dose response relationship between the reported 
symptoms and air pollution. The results showed a high frequency of observations at levels ≤20 
µg/m3 to ≤30-µg/m3 for all of the month months. The extreme levels of ≤10 µg/m3 and >50 
µg/m3 showed the least frequency of PM10.  For further visualization of this result, the percent 
frequency observations and the PM10 increments were plotted (Figure 14) and showed that the 
month of June 2003 had highest levels of PM10 levels between levels ≤20 µg/m3 to ≤30 µg/m3. 
The months of October and November 2003 had the highest peak levels around ≤ 0 µg/m3.   
To assess a dose-response relationship between PM10 and cardiopulmonary symptoms 
outcomes, a Mantel Haenszel Chi-Squ carried out for the ordinal measure of 
significance. The M-Hχ2 was applied to assess whether PM10 increments of 10µg/m3 are 
associated with frequencies of having symptoms. The M-Hχ2 results showed a significant effect 
at p <0.05 between the symptoms of cough in the morning (p=0.0419), frequent cough (p=0. 
0.0431and being awakened by shortness of breath (p=0.0332) and PM10 increments of 10µg/m3 
exposures (Table 21).    
A general chi-square (χ2) cross tabulation analysis was carried out using SPSS version 
12.0.1 to assess an association of the10 µg/m3 increments of PM10 on morning PEFR changes 
and symptoms. The χ2 analysis showed strong effect at p<0.05 with significant association 
between PEFR decrements ≥10 and cough in the morning (p=0.007), cough during the day 
(p=0.021) and wheezing (0.051); The results also showed a significant association (p<0.05) 
betwe n the 
2
are (M-Hχ2) test was 
en PEFR decrements not greater than 10% from the mean and symptoms of cough i
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morning, co  du g on level 
ground (Table 22).  
The General Estimating Equation (GEE) analysis GENMOD procedure in SAS was used 
to estimate the risk the PM  increments of 10 µg/m3 (categories) on frequency of the symptoms 
and by study period (seasonality). The odds ratio for the model was obtained by exponentiation 
of the parameter estimate for the independent variables in the GENMOD procedure and the 
output also produces along with the OR, the 95% confidence interval.  The probability that 
participants will report symptoms with changes in PM  was analyzed. The results indicated 
significant effect for cough in the morning (p=0.0141) when PM  increases by 10 µg/m3.  The 
odds ratio (OR) and 95% confidence interval (CI) was OR 1.12, (CI= 1.02– 1.23) (Table 23).  An 
analysis of the initial parameter estimates (logistic regressions) showed that the seasonality 
(study period) had an influence on symptoms outcomes. The study period of October 2003 had a 
significant effect on cough in the morning (p= 0.0209) and the month of November 2003 had a 
marginal influence (p= 0.0868). The study period of June 2003 had a significant influence on 
being trouble by shortness of breath (p=0.0121) and on “stopped for breath while walking on 
ng the meteorological variables using a 
backward e
ugh ring the day, frequent cough and stopping for breath while walkin
10
10
10
level ground” (p= 0.0172).  
We performed PROC GENMOD analysis by addi
limination in the model to assess the effect of the independent variables on the 
symptoms.  Initially all the independent variables of interest were added into the model followed 
by elimination from the model in an iterative process of variables with the least significance.  
Effects of independent variables such as weather and exposures to tobacco are thought to be 
confounders of ambient air pollution. Cardiopulmonary conditions such as asthma, and chronic 
obstructive pulmonary disease (COPD), can be triggered by cold and dry air weather conditions, 
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and seasonal pollen and infectious diseases.  Effects such as those of smoke and other indoor 
pollution are constant during a short-term observation study and therefore are not considered to 
confou
4.9 Risk Estimates of Cardiopulmonary Symptom and Medication Use 
or windows to see if there is an association among the parameters. 
The rel
 
nd the air pollution.  Additionally, the weather variables were significantly correlated to 
each other and therefore decided to examine only the effects of the weather and seasonality on 
symptoms in the regression model. The relative risk (odds ratio) and the confidence limits and 
significant relationship at p<0.05 of experiencing cardiopulmonary symptoms when exposed to 
10 µg/m3 incremental levels of PM10 are shown in Table 24. The risk estimates were significant 
for cough in the morning was (p< 0.0010), cough during the day (p=0.0008), chest pain 
(p<0.0001), fatigue (p=0.0153), stopping for a breath while walking on level ground (p= 0.0487) 
and wheezing (p=0.0013).  
  
Table 25 shows the characteristics estimate of symptoms and use of anti-inflammatory 
medication. The effect was explored by carrying out a chi-square (χ2) analysis and risk estimate 
using SPSS version 12.0.1 f
ationship between symptoms and anti-inflammatory medication use showed that the risk 
for cough in the morning (OR 3.99; 95% CI 2.47-6.46) and during the day (OR 5.15; 95% CI 
3.13-8.48), phlegm in the morning (OR 5.29; 95% CI 3.20-8.69) and wheezing (OR 1.15; 95% 
CI 0.78-1.71), was greater if the individual was not on medication.  
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Table 20: Frequency of 10 µg/m3 PM10 increments by study period 
 
Mean 24-hr PM10 
Category 
June 2003 October 2003 November 
2003 
April 2004 
 *n % *n % *n % *n % 
≤ 10 µg/m3 8 3.3 24 9.0 40 16.7 30 20.0 
≤ 20µg/m3 39 16.3 90 33.8 99 41.3 50 33.3 
≤ 30µg/m3 128 53.6 43 16.2 24 10.0 40 26.7 
≤ 40 µg/m3 24 10.0 48 18.0 30 12.5 10 6.7 
≤ 50µg/m3 16 6.7 43 16.2 23 9.6 20 13.3 
> 50µg/m3 24 10.0 18 6.8 24 10.0 0 0 
 
Total 239 100 266 100 240 100 150 100 
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Table 21: Summary of association between d PM10 by increments of 10 
 
 
*Significant at p <. 05. **Degrees of Freedom 
 
 
 
 
Health Outcomes **DF Mantel Haenszel 
are  
p-value 
 
 symptoms an
µg/m3  
Chi-Squ
Frequent cough 1 4.0931 0.0431* 
Cough in the morning 1 4.1403 0.0419* 
Cough during the day 1 0.0310 0.8603 
Phlegm in the morning 0.0 0.867 1 279 3 
Phlegm during the day 1 2.8626 0.0907 
Troubled by shortness of breath 1 1.0520 0.3050 
Stopped f
 
or breath whi alking vel gr  1.1 0.2739le w  on le ound 1 972  
Wheezing 1 0.2343 0.6284 
Chest pain 0.8 0.3461 872 2 
Shortness of breath  3.37 0651 1 71 0.
Fatigue 1 2.4724 0.1159 
Awakened by shortne reath 4.5 0332* ss of b  1 350 0.
Total symptoms 1 3.1715 0.0749 
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Table 22: Summary association of sympto s by morning PEFR changes with PM10   
 
 
Health Outc PEFR Decrements ≥ 10% PEFR Decrements ≠ >10% 
 
 
m
increments of 10 µg/m3  
omes 
 **DF Chi-
Square 
p-value **DF Chi-
Square 
p-value 
Frequent coughing  5 9.302 0.09 5 12.994 0.023* 3 
Co 5 16.030 0.00  5 18.236  ugh in the morning 6* 0.003*
Co 5 13.280 0.019* 5 15.697  ugh during the day 0.008*
Ph 5 5.074 0.4 5 9.561 88 legm in the morning  16 0.0
Phlegm during the day 5 4.550 0.48 5 10.525 0.061 4 
Troubled by shortness 
of 
5 7.387 0.19 5 10.003 0.075 
breath 
3 
Sto
wh on level 
ground 
5 1.153 0.9 5 10.625 59 pped for breath 
ile walking 
55 0.0
W 5 11.018 0.048* 5 6.823 32 heezing 0.2
Chest Pain - - - 5 24.864 0.000* 
Shortness of breath 5 13.247 0.021* 5 12.752 0.025* 
Fatigue 14.054 0.016* - - - 5 
Awakened by shortness 
of breath 
5 32.200 0.001* 5 7.325 0.195 
*Significant at p < .05. **Degrees of freedom 
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Table 23: Relative Risks (OR) of the presence of symptoms among participants by PM10 
exposure increments of 10 µg/m3 controlling for seasonality 
 
 
Variable OR 95% ce I p-valu Confiden nterval e 
Cough in the morning 1.1216 -1.2293 0141* 1.0234 0.
Cough during the day 1.0402 0.9593-1.1280 0.3393 
Phlegm in the morning 1.0633 0.9746-1.1600 0.1672 
Phlegm during the day 0.9483 0 -1.0309 .2132 .8724 0
Troubled by shortness
breath 
 of 0.9823 -1.0448 .57090.9235 0  
Stopped for breath wh
walking on level ground 
ile 0.9860 -1.0403 .60640.9346 0  
Wheezing 0.9895 .0634 .7737 0.9207-1 0  
* Significant at p <. 05 
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Table 24: Relative Risk (OR) of symptoms
Symptoms OR 95% Confidence Limits p-value 
 by PM10 increments of 10 µg/m3 and after 
controlling temperature, relative humidity, pressure and seasonality 
 
 
 
Frequent coughing  1.0490 0.9178-1.1991 0.4829 
Cough in the morning  73 <01.4464 1.2473-1.67 .0001* 
Cough during the day  38 0.1.2937 1.1129- 1.50 0008* 
Phlegm in the morning  1.0721 0.9775-1.1759 0.1395 
Phlegm during the day 0.9566 0.8810-1.0386 0.2902 
Troubled by shortness of 
breath 
 
 30 00.9964 0.9429-1.05 .8991 
Stopped for breath w
walking on level grou
hile 
nd 
 
40 4 0.0.89 0.7998-0.999 0487* 
Wheezing 1.3077 0 0.1.1103-1.540 0013* 
Chest pain 0.6563 0.5798-0.7428 <0.0001* 
 
Shortness of breath 1.0190 0.09564-1.0856 0.5607 
Fatigue 0. 8-0.9341 0.0153* 7015 0.526
Awakened by shortness 
of breath 
 
1.1285 0.9356-1.3611 0.2062 
* Significant at p <. 05 
 
 
 
 
 
 
 
 
 95
 Table 25: Relative risk (OR) of symptoms among participants by anti-inflammatory 
medication use 
 
Symptoms Anti-inflammator Medication 
use 
N=640 
No Anti-inflammatory 
Medication use 
N=255
 
 
 
 
 
 
y 
 
 OR  Confide  Conf terval 95% nce Interval OR 95% idence In
Freq 2.44 - 3.30) (0.29 - 0 .4uent cough (1.81 0.34  1) 
Cough in the morning 0.72 (0.68 - 0.77) 3.99  (2.47 - 6.46) 
Cough d 0.69 74) (3.13 - 8.48uring the day (0.65 - 0. 5.15  ) 
Phle 0.69 - 0 .75) (3.20 - 8.6gm in the morning (0.65 5.29  9) 
Phle 65 - 0.69) (6.65 - 38.gm during the day 0. (0.61 15.91  04) 
Tro
breath 
.74 - 0.80) (2.10 - 5.2ubled by shortness of 0 (0.69 3.33  9) 
Stop ath while 
walking on level ground 
0.84 - 0.92) (1.21 - 2.4ped for bre (0.77 1.73  7) 
Wheezing 0.95 ( 3 - 1.09) 1.15  (.78 - 1.71) 0.8
Ches 12.98
3 
-49.894) 0 (0.261-0.3t pain (3.378 .274 15 
Shor 2.937 -4.095) (0.261-0.3tness of breath (2.107 0.310 69) 
Awakened by shortness of 
breath 
6.518 0.280 (0.240-0.327) (3.068-13.948) 
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5.0 DISCUSSION  
5.1 Particulate Matter  
The udy exam n am tion and 
outcomes of cardiopulmonary sym tom us  a se
design approach.  The trend of PM10 in Allegheny County is shown in Figure 2 for years 1995- 
2000, and for the period of May 2003 to May 2004 in Figures 8-9. The average 24hr PM10 levels 
ranged from 30.84 µg/m  in year 1995 to 25.57 µg/m3 in year 2000. The average 24hr PM10 
levels for the period of May 2 o as 24.36 µ  T s show that the 
ambi ghen n ing. In both ie ata evaluation, 
SHA show  le onths 
and h s o ob ber. All of the 8 continuous monitoring sites 
were highly correlated and statistically significant (p<.01) during the SHAPE study (Table 13). 
Libe wed slightly lower correlation coefficients compared to the other 7 
monitors.  This observation endows an opportunity to evaluate the current 
moni cy. New strate o programs n nal monitoring 
whic alculate p rate indiv ost 
susceptible individuals in the community. 
earlier studies have shown that PM10 is a risk factor for cardiopulmonary hospital 
and emergency room visits (Schwartz 1994; Morris 2001; Peters et al., 2001). This could be due 
to the composition of the inhalable particles of a mixture of combustive by-products and re-
suspended crystal material as well as biological materials such as pollen, endotoxins, bacteria 
SHAPE st ined an association betwee bient air PM10 pollu
p s i ult cohort n an ad ing mi-individual longitudinal 
3
003 t May 2004 w g/m3. hese result
ent air quality in Alle y Cou ty is improv  stud s (PACCC d
PE) the air pollution  low vels of ambient concentrations during the winter m
igh levels in the month f Oct er to Decem
rty monitoring site sho
regional air pollution 
toring poli gies c uld integrate  that i clude perso
h can efficiently c  and a portion accu idual daily exposures of the m
The 
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and viruses (Levy et al., 2002; Verrier et al., 2002, Jinsart et al., 2002; Aekplakorn et al., 2003). 
dditionally, several biological mechanisms both in animals have shown that the particulate 
matter can induce pro-inflammatory di ue following exposure to variable 
levels of concentrations. Yeates and Manderly echanisms of air 
pollution on cardiovascular and systemic responses and how non-respiratory organ health 
outcom
ission type (multiple admission versus one-time 
admiss
A
 con tions in lung tiss
(2001) summarized studies on m
es can occur following air pollution deposition in the respiratory tissue. A possible 
contribution to the mixture of ambient air concentrations in Allegheny County are the power 
plants and toxic release inventory (TRI) sites (Table 8), and possible combustive by-products and 
re-suspended crystal material from automobile (Figure 7).  It is essential to carry out regional 
studies because of the differences in chemical mixtures influenced by local emissions. 
 
5.2 Cardiopulmonary Symptoms  
In the analysis of the admission data of the Pennsylvania Cost Care Containment (PACCC) of 
years 1995-2000, we observed that 43% of the adults aged ≥ 65 years are admitted for 
cardiopulmonary reasons (ICD-9 Codes 390-519, Tables 3&4). The results also showed that the 
elderly who were admitted multiple times had diagnoses of acute conditions compared to those 
admitted only one time during the 6 year period. A logistic regression model controlling for 
weather, seasonality and day of the week of admission and age group showed a significant 
relationship (p< 0.0001) between adm
ion) and the average 24-hr PM10.  In the SHAPE follow-up study, the results showed 
relationships between PM10 levels and cardiopulmonary symptoms. Significant relationships 
were shown between frequent cough, cough in the morning and being awakened by shortness of 
breath and increments of 10 µg/m3 PM10 (Table 21) and a risk estimate only showed significant 
 98
relationships with cough in the morning (Table 23).  The study did not show significant 
relationship between increments in 10 µg/m3 PM10 and wheezing before adjustments for 
covariates. Other studies (von Klot et al., 2002; Zemp et al., 1999), reported that there was no 
association with wheezing, chest tightness and air pollution. When a risk estimate was carried 
out adjusting for weather and seasonality, an association between cardiopulmonary symptoms 
and increments in 10 µg/m3 PM10, was strengthened (Table 24). This result shows that after 
controlling for the weather variable of temperature, relative humidity and pressure and 
seasonality, the physiological responses appear to be related to PM10 exposures. For cough in the 
morning the OR was 1.12 (95% CI =1.02- 1.23), for an increase in 10 µg/m3 adjusting for 
seasonality (Table 23). The SHAPE study showed some consistency with other studies that have 
own effects of low-level ambient air pollution and acute adverse cardiopulmonary health 
effects.  
In this study, the average 24-hr PM10 was 24.36 µg/m3, which is far below the federal 
sh
ambient air quality standard of 150 µg/m3. The annual arithmetic standard for PM10 is 50 µg/m3. 
The acute health effects observed are often reversible health conditions (PEFR, phlegm, cough, 
and shortness of breath) which improve following removal of an exposure or following 
treatment. This is often seen in occupational settings where a worker who is experiencing the 
effects of occupational exposures can often recover completely once removed from the nuisance 
exposure (Nieuwenhuijsen & Burddorf, 2001). Practical short-term intervention studies of 
ambient air pollution are not common. In an intervention study of the ban of coal use in Dublin, 
Ireland, Clancy et al., (2002) showed that after 72 months about 116 fewer respiratory deaths and 
243 fewer cardiovascular deaths were seen per year. This accounted for 5.7% decrease in 
respiratory death (95% CI, 4-7, p<0.0001) and for the cardiovascular death by 10.3% (95% CI, 
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8-13, p<0.0001). The intervention clearly shows the benefits of dealing first with the bigger 
contributors to air pollution. 
Scatter plots of PEFR changes were not associated with PM 10 changes (Figure 12-13). It could 
be that PEFR is not a sensitive tool for evaluation of pulmonary function in adults. A significant 
relationship was shown between PM10 and increased decrements of 10% pulmonary function as 
measured by the PEFR and cardiopulmonary symptoms of cough (Table 22).  But we also 
observed a significant relationship (p<.05) for PEFR decrements less than 10% for cough in the 
morning and during the day, frequent cough, and for stopping for breath while walking on level 
ground. This could be that as PM increases the already vulnerable people react more adversely 
than heal
5.3 Peak Expiratory Flow Rate (PEFR) 
thier people would to even small changes in air quality. PEFR essentially is a surrogate 
measurement of FEV1 but FEV1 is measured often in a pulmonary laboratory, whereas, PEFR is 
often self-administered and can be prone to errors.   Future studies measuring PEFR could also 
include measurement of a series of FEV1.   
Not many studies have shown a relationship between PM exposures and PEFR. 
Significant negative associations were reported by Roemer et al., (1998) and Pentinnen et al., 
(2001).  Osunsanya et al., (2001) reported borderline significant (p< .05), with 19% increase in 
the rate of 10% decrements in daytime PEFR with increase in PM10 of 10-20 µg/m3.  Boezen et 
al., (1998) reported a high significant prevalence of symptoms with increase in PM10 in adults 
who had a greater variability of PEFR. Koeing et al., (1993) showed that an increase in fine 
particulate was associated with declines in forced expiratory volume in 1 second (FEV1) by 34 
ml for an increase in PM10 of 20 µg/m3.  
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A low significant relationship between wheezing and PM10, adjusting for PEFR of 10% 
from the mean was observed (=0.048) (Table 22). Wheezing is of interest in respiratory symptoms 
as normally, this is one of the overt signs of changes in breathing patterns of asthma patients.  In 
the Pollution Effects on Asthma Children in Europe (PEACE) studies by Roemer et al., (1998) 
5.4 Medication Use and Symptoms 
 the medication it is speculative to discern that the 
individuals were taking the medication because they needed to take the medication to alleviate 
that involved children, the authors reported that PM10 was associated with wheezing outcomes.  
Boezen, (1998) reported that there was no consistent association between PM10, NO2, SO2 and 
black smoke with respiratory symptoms, but reported an OR of 1.10 (95% CI= 0.81-1.31) for a 
5% decrease in PEFR to PM10 exposure of average 41.5 µg/m3.  The SHAPE study showed that 
individuals who took their anti-inflammatory medication as much as 100 % of the time 
(Figure11) reported symptoms outcomes 50% of the time. It could be that wheezing symptoms in 
adult groups is well controlled by use of medication. Conversely, this may not be the case in 
children who rely on adults to regulate their medication, and hence most studies of children show 
a significant relationship between air pollution and wheezing.  Future studies should explore this 
medication phenomenon in different age groups. 
Medication has been reported to be protective of symptoms of the cardiopulmonary system. In 
this study an increased prevalent use of anti-inflammatory medication among participants 
(Figure 11) was reported. Over 59% of the participants were on anti-inflammatory medication. 
When medication use was analyzed by study period, the results showed that in October, 2003 
individuals reported use of anti-inflammatory medication 71% of the time and also reported 
having symptoms 71% of the time during the same period. Because the study did not obtain 
complete data on the patterns of taking
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the sym
5.5 Emergency Room Visits and Hospital Admissions 
a great deal to our understanding of insidious 
currents that occur before an individual seeks medical help.  In this study very few incidences of 
emergency room visits, doctor’s visits and hospitalizations were observed.  Undoubtedly, higher 
ptoms. In other cases however, the elderly take their medication simply because the 
doctor prescribed it, a phenomenon reported by Curtis et al., (2004).  In fact, when a risk 
estimate analysis was performed the results showed that non-users of anti-inflammatory 
medication were at higher risks of experiencing the cardiopulmonary symptoms compared to 
those on the medication (Table 25).  In a study involving children however, Delfino et al., (2002) 
reported significant association between symptoms among kids who were not taking anti-
inflammatory medication and criteria pollutants of PM10, O3 and NO2.  Future study analysis 
should report on the environmental triggers that can influence the study participants to regulate 
their anti-inflammatory medication use. This can contribute to accurate measurement of the 
cardio-respiratory response under unpredictable concentrations of air pollution. 
 
Longitudinal follow-up studies can contribute 
ambient air pollution exposures seen in earlier studies can be implicated for hospital admissions 
or death in different population groups.  But, lower levels of ambient air pollution exposures as 
seen today do not necessarily cause death, accelerate death, or shorten life by a few hours or 
days, or lead to frequent hospitalization or emergency room visits but can result in repeated acute 
symptoms that can be reversed once exposures are removed (Nieuwenhuijsen & Burddorf, 
2001). Continued exposures at levels that are thought to be safe can aggravate the symptoms and 
can eventually compromise physiological cardiopulmonary function. This has implications to 
ambient air quality that can be improved to protect all groups of individuals in a community. 
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The SHAPE study followed up individuals who monitored their health by using a self-
administered pulmonary function test and keeping records of cardiopulmonary symptoms as well 
as daily activities. Since short-term exposure are likely to cause overt symptoms, it is important 
to have knowledge and background health history of study participants in air pollution studies in 
order to detect these small changes observed and to make correct inferences of any significant 
outcomes.  All the participants had a physician confirmed diagnosis of cardiopulmonary disease. 
The study showed results that have small estimates to the population but are 
5.6 Conclusion 
not insignificant 
suggesting that the elderly susceptible individuals may be at a greater risk of developing 
symptoms if exposed to the currently observed low-levels of exposure.  There is some 
consistency between the results of this study and the results of studies performed elsewhere 
(Table1). Even after controlling for potential confounders we found that the PM10 concentrations 
are significant in exerting cardiopulmonary symptoms in this susceptible population. 
Mortality studies on low levels of ambient air particulate exposures have shown that the 
elderly are significantly at risk of death from cardiopulmonary causes compared to the younger 
adults (Fischer et al., 2003; Vedal et al., 2003). A few morbidity studies on hospital and ER visits 
and air pollution studies have also shown that the elderly are especially at risk to low-ambient 
exposure level (Hwang &Chan, 2002).  Follow-up studies that have included the elderly and the 
disadvantaged communities have shown how the African Americans and those with lower 
education attainment can experience consequential health outcomes by living close to power 
plants ( Levy et al, 2002). 
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The SHAPE study restricted recruitment and participation of individual to an area defined 
by zip codes and within 15 km of known polluting sources. Although we included all the data 
from Allegheny County continuous monitoring sites, this should not be necessary in future 
otect those 
groups 
5.7 Study Limitations and Implications 
alysis in order to create a homogenous group for comparison. As a 
result, our study did not consider separate analysis for different diagnosis to see which groups of 
studies because these sites were highly correlated. Individual monitoring can be more benefitial 
to the communities and also to the advancement of air pollution studies.  Individual 
apportionment of exposure and control of study area improves on the study outcomes inference 
and is recommended for future studies. More regional research investigations targeting the 
susceptible populations such as the elderly are needed. Implications of such study findings can 
influence policy changes that can lead to increased attention to ambient air quality regulations 
and consequently improved quality of life among different groups of populations.  The federal, 
state and the county agencies should re-evaluate their monitoring strategies to incorporate the 
best science that protects individuals.  It is not important that the industrial companies meet the 
current standards, but that individuals at risk of being impacted by these low level exposures are 
protected. The state and federal agencies and environmental and epidemiology scientists should 
ask the question whether the current USEPA standards are stringent enough to pr
of people that are most susceptible such as the sick, elderly, children, those with less 
educational attainment and different ethnic groups and whether the current monitoring programs 
are over due for a review.  
 
Sample size for estimation of association was small. Forty-seven percent (47%) of our data was 
excluded from the final an
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people are most affected by air quality.  Future longitudinal studies could evaluate separately the 
effects of air pollution on individuals who have  cardiovascular disease and those  who 
have respiratory disease diagnosis.   Additionally, this study  based exposure of individuals 
on ecological exposure;  the assumption of this type of study is that all participants are 
exposed to  the same levels of particulate matter in a given period.   The effect on all 
participants will be relatively similar regardless of health condition.  Future studies may 
require funding to include individual monitoring to improve on the extrapolation of individual 
exposure matrix.   
The implications of the SHAPE study are that very few hospital or emergency room visits 
are reported yet a large percent of individuals reported symptoms. This signifies that the 
susceptible populations may be sensitive to the currently recorded levels of ambient air and that 
they react adversely but not severe enough to require medical support.  These small incidences 
can eventually burden the body leading to hospitalization or death. Although this study did not 
assess the outcomes by ethnicity groups or educational level, it is reasonable to conclude that a 
large percent of population in the study area are employed in the industrial plants and that the 
population includes different ethnic groups that live and work in the vicinity of the power plants 
and coke oven plants. Future studies that explore these factors are recommended.  
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APPENDIX A: ENVIRONMENTAL HEALTH STUDY QUESTIONNAIRE 
 
 1. Study Code identification number “CIN”                                               1.             
 2. Name____________________________                                                          2.             
  Address________________________ 
  ________________________ 
 3.  Telephone number                                                         3.              
 4. 
 5 Sex (M/F)                                                                         5.   
   Codes: (00)if YES;   (88)NO;   (99)UNKNOWN 
   If yes, what disease and at what age (in years)? _____                                                                 9.    
  10.   Have you ever been to the emergency room for lung problems?  NO   YES 
   If yes, what heart problem and how many times? _____________                                            11.    
   Codes:  (88)NO;   (number of times)YES;   (99)UNKNOWN 
 
 12.  Have you ever been placed on a ventilator (a machine that breaths for you while you have a plastic 
tube in your mouth/lung?)  (0)NO   (1)YES   (9)UNKNOWN                                                             12.   
        
 13.  What factors aggravate your respiratory or heart problems or bring on an attack? 
   13a.  cold air   (0)NO   (1)YES   (9)UNKNOWN                                                                          13a.   
   13b.  humidity   (0)NO   (1)YES   (9)UNKNOWN                                                                       13b.   
   13c.  exercise   (0)NO   (1)YES   (9)UNKNOWN                                                                          13c.   
   13d.  medication   (0)NO   (1)YES specify:_________________________                                 13d    
   13e.  change of seasons   (0)NO   (1)YES   (9)UNKNOWN                                                         13e.   
   13f.  dust or dander (animal)   (0)NO   (1)YES   (9)UNKNOWN                                               13f.   
   13g.  other   (0)NO   (1)YES specify:_______________________________                               13g.   
                                       (9)UNKNOWN 
 
 
Date of Birth________________________                                                              4.            
 6. What is your racial/ethnic background?                                                                      6.    
(01) African American/Black;  (02) White/Caucasian; (03) Hispanic; (04) American Indian (05) 
Asian/Pacific Islander;  (99) Other 
 7. Date of interview (mm dd yyyy)                                                             7.             
   
 8. Have you ever been told by a physician that you have a lung disease such as asthma?  NO   YES 
   If yes, what disease and at what age (in years)? ________                                                            8.    
 
     9. Have you ever been told by a physician that you have heart problems?  NO   YES 
   Codes: (00)if YES;   (88)NO;   (99)UNKNOWN 
 
   If yes, what lung problem and how many times?_____________                                              10.    
   Codes:  (88)NO;   (number of times)YES;   (99)UNKNOWN 
 
 11.  Have you ever been admitted to the emergency room for heart problems? NO   YES 
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APPENDIX A (Cont’d) 
 
 
14.        Have you ever taken medications for lung problems? (0)NO (1)YES*(9)UNKNOWN                      14.                               
   If yes, please list for each medication ever
Drug Name; Route (nasal spray, oral inhal  Dose (in number of sprays, puffs or mg); 
  
 
  
 _______________________________________________________________________ 
  
____________
5  lung disea
________
 heart problem?  
ircums
 
    _ __________
  H   
s);   Dose (in number of sprays, puffs or mg); 
__
__ _____________ 
am
9.    H ve ems in the past year?                19.   
__
__
0.   H w 
KNOWN 
2.     Are there rooms including basement in the house that are damp? 
   (0)NO   (1)YES                                                                              22.   
 
 used: 
er, pills);
 Frequency (times per day; less than once a week; etc); Date started; Date stopped 
_______________________________________________________________________ 
 _______________________________ ____________________________ 
1 .    Are you still being treated for asthma or se?(0)NO(1)YES     (9)UNKNOWN                 15.   
__________________________   Name of Medications_________________
 
6  H  out or had a1 .      ave you ever passed (0)NO   (1)YES   (9)UNKNOWN                       16.   
   If yes, please list: 
pe of event, triggering factors/c   Date, ty tances 
  
 _______________________________________________________________________ 
_____        ____________________________ ___________________________ 
     
 17.    ave you ever taken medications for heart problems?   (0)NO   (1)YES*   (9)UNKNOWN              17. 
   If yes, please list for each medication ever used: 
Drug Name; Route (nasal spray, oral inhaler, pill
 Frequency (times per day; less than once a week; etc); Date started; Date stopped 
  
__________________________  _ __________________________________________
  
___ _ ___________________________________________________________________ 
  
 _ _______________________________________________________
    
8. re1  A  you still being treated for heart problems?  (0)NO   (1)YES   (9)UNKNOWN                           18.   
N e of Medications_______________________ ___________________  
 
  a you been admitted to a hospital for respiratory or heart probl1
  (0)NO   (1) YES (9) UNKNOWN If yes, please list: 
   Date, reason, and hospital, county, state 
  
 _______________________________________________________________________ 
  
 _ ____________________________________________________________________ 
  
 _ ____________________________________________________________________ 
2    o old is the house that you live in now?                                                                             20.    
  (Enter age) YES     (99)UNKNOWN 
 
2    o long have you lived in this house.                                                                                    21.    1.   H w 
 (Enter years) YES    (99)UN
 
2
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 3.   W at i
.    
 
 
 
 
legheny County ?                                    25.   
 
 
                      26.   
 
 
 
 
APPENDIX A (Cont’d) 
 
2   h s the main source of heating in your home? 
  umber given for each heating source below)    
 
(Enter a N                                                            23
      (11) Radiators (steam or water) 
             (22) Gas- heated forces air (vents) 
             (33) Electric- heated forced air (vents) 
             (44) Gas stove/ fireplace/ wall furnace 
             (55) Electric space heater 
             (66) Kerosene space heater  
                (77) Wood burning stove/ fireplace    
   (99) UNKNOWN 
 
24.     How long have you lived in Allegheny County?                                                                            24.    
 
25.  e air pollution gotten better since you first lived in Al    Has th
 (0) NO; (1) YES; (9) UNKNOWN 
  
  26.     Do you smoke?  
O   (1)YES                                                       (0)N        
 
7.      Are y                                                                           27.   2  ou exposed to tobacco smoke in your home?     
   (0)NO   (1)YES   
 Than
  
k you for taking time to answer this survey.  
 28.F 28b.                                       
         Staff Code 
 29.F 9b.                                  
 Staff Code 
orm com
                  Month         day            year                
ked by     _______________________ 29a.                  2
pleted by _______________________ 28a.                                              
orm chec
            Month         day            year                
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DA S DIARY {LUNGS} 
 
APPENDIX B:  DAILY PEAKFLOW AND SYMPTOMS DIARY 
ILY PEAKFLOW AND SYMPTOM
 
P , M  1 2 3 4 5 6 7 
                                                  D
ak Flow edication and Symptoms 
       ate 
e
Record your best Peak flow this morning (before medication)        
Record your best Peak flow this afternoon? (Between 2 PM and 6PM)        
D
b nk ased = 1     
D
id you chan pecify medication        ge your medication today? Please s
 response as follows: No = 0    Increelow.  Ra  your
ecreased = 2.   
        
        
        
D
response follows: No = 1   Moderate =2    Severe =3  
id you h ve ng symptoms today?  Please rank your        a any of the followi
as 0    Mild =
A        ny cough first thing this morning? 
                     Any cough during the day? 
              Any phlegm first thing this morning?         
              Any phlegm during the day?         
              Troubled by shortness of breath?        
Stopped for breath while walking on level ground?        
 Any wheezing or whistling sound from your chest?                  
Did you ve any of these other symptoms today?  Y or N        ha
             Muscle aches?          
             Nose congestion?         
             Runny nose?         
             Sore throat?         
             Fever or shaky chills?         
             Headache?         
Did you have a visit to the ER today? Y or N        
Did you have an unscheduled visit to your doctor today? Y or N        
How long were you outdoors today?  
Please Enter Number of Hours. If None Enter 0. 
       
If you smoke, how many cigarettes did you smoke today? If none 
enter 0 
       
Were you exposed to tobacco smoke (secondary smoke) today? Y or 
N 
       
Were you more than 10 miles away from your home today? Y or N        
If you were more than 10 miles away from home,   
Enter Number of Hours.  If None Enter 0 Hours. 
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APPENDIX B (Cont’d) 
 
 
 
DAILY PEAKF
 
LOW AND SYMPTOMS DIARY {HEART} 
                                                          Date 
Peak Flow, Medication and Symptoms  1 2 3 4 5 6 7 
Record your best Peak flow this morning (before medication)        
Record your best Peak flow this afternoon (Between 2 PM and 6 PM)        
Did you change your medication today? Please specify medication 
d = 2  
       
below. 
Rank your response as follows:  No = 0  Increased =1  Decrease
        
        
        
Did you have any of the following symptoms today? Please rank you
response as follows: No =0    Mild =1    Moderate = 2    Severe = 3 
r        
Experienced any chest pain during activities?        
 Experienced any shortness of breath during activity?        
             Experienced unexplained weakness or fatigue?        
              Awakened by shortness of breath?        
              Experienced any frequent coughing?              
Did you have any of these other symptoms today? Y or N        
             Muscle aches         
             Nose congestion/ Runny nose?         
             Sore throat?         
             Fever or shaky chills?         
             Headache?         
Did you have a visit to the ER today? Y or N        
Did you have an unscheduled visit to your doctor today? Y or N        
How long were you outdoors today?  
Please Enter Number of Hours. If None Enter 0. 
       
If you smoke, how many cigarettes did you smoke today? If none 
enter 0 
       
Were you exposed to tobacco smoke (secondary smoke) today?  
Y or N 
       
Were you more than 10 miles away from your home today? Y or N        
If  you were more than 10 miles away from home,   
Enter Number of Hours.  If None Enter 0 Hours. 
       
 
*The diary comprised of a one calendar to make it easier for  
 participants' record keeping. This diary has been modified here to fit
the page.  
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